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PART I SUMMARY 
 Summary 
The triad of the phylogenetically related protozoan blood parasites Babesia, Plasmodium and 
Theileria are the causative agents of important human and veterinary diseases worldwide. Canine 
babesiosis, a persistent endemic disease in diverse dog populations, is caused by apicomplexan hemo-
parasites of the genus Babesia. Parasite host transmission is mediated by ticks and is facilitated by the 
international and domestic transportation of dogs as well as the focal availability of tick vectors. The 
presence of chronic subclinical carrier states in dogs, the inability to completely eliminate all infections, 
and the transovarial transmission of the parasite within the vector tick population further lead to a 
spreading of new infections. 
Babesia canis is the predominant and clinically relevant canine Babesia species in Europe. 
Although the pathophysiology of canine babesiosis has been extensively studied, parasite-host 
interactions of the parasite are poorly understood. In common, the peripheral parasitemia remains 
usually low which however does not prevent severe clinical signs and high fatality rates. Hence, the 
pathogenic capacities of B. canis lie within the secreted factors, all of which have been poorly 
characterized. This PhD project aimed to characterize key factors involved in B. canis infections, such 
as the B. canis secretome which affects infected erythrocyte biology (Subproject 1), the description of 
clinical factors and pathophysiologic mechanisms of babesiosis in dogs (Subproject 2), and the analysis 
of tick-vector dissemination after a locally restricted outbreak of B. canis (Subproject 3). 
Like other apicomplexan parasites, B. canis has developed a repertoire of organelles, pathways 
and strategies to survive, subsist and replicate within the infected host-cell. In a first subproject, we 
assembled and annotated the B. canis reference genome from a virulent Hungarian parasite strain to 
generate an understanding of B. canis virulence and pathogenicity factors. Out of the 3467 predicted 
gene models we identified 509 potential secreted parasite proteins. To identify specific parasite 
protein candidates involved during acute crisis of the disease, we analyzed the B. canis blood stage 
proteome and transcriptome using parasites isolated from experimentally infected dogs. Our data 
indicate the presence of parasite factors involved in cytoadherence, immune evasion, and infected red 
blood cell remodeling. These combined analyses provide a predicted and partially validated set of 
exported factors from B. canis blood stages potentially involved in the direct parasite-host interplay 
during the acute phase of the disease. 
In a second subproject, we focused on host factors during acute B. canis infections which are 
associated with severe and fatal clinical outcomes. By examining 28 different laboratory parameters 
in 15 naturally infected animals at the time of first admission and before any treatment on the one 
hand, and in the course of 3 experimentally infected dogs on the other hand, we uncovered 7 
prognostic markers associated with poor outcomes. Severe clinical outcomes were associated with 
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moderate anemia, severe thrombocytopenia, mild to moderate leukopenia, hyperlactatemia, 
moderately increased serum phosphate and triglyceride concentrations, and moderately decreased 
total serum protein concentrations. However, prognosis is not correlated to clinical signs or the level 
of parasitemia which remains usually low. Hence, altered laboratory parameters could be attributed 
to an excessive host immune-response contributed directly by parasite induced septic conditions. 
In a third subproject, we investigated the occurrence of the vector tick following a recent 
outbreak of B. canis babesiosis in northeastern Switzerland. Data about tick species infesting dogs and 
cats are generally rare. Changes in the endemic foci of tick populations and invasions of tick species 
into new areas have become evident in Europe, leading to continuous changes in the epidemiology of 
tick-transmitted diseases. By a novel local pet-owner assisted sampling strategy we investigated the 
occurrence of different tick species on dogs and cats and focused on the presence of D. reticulatus, 
which is the tick vector for B. canis babesiosis. We identified Ixodes ricinus as the most abundant 
species on both hosts, followed by I. hexagonus and D. reticulatus both with prevalences below 2%. 
The local occurrence of D. reticulatus was confirmed by collecting ticks in a marsh-like environment 
with open meadows, loose trees and intense solar radiation. Our sampling strategy allowed to identify 
for the first time the vole or shrew tick I. trianguliceps on cats. Our survey demonstrated that pet 
owners can assist in collecting important epidemiological data on local tick species and contribute to 
a cost-effective tick surveillance, thus laying the groundwork for the investigation of local tick-
transmitted diseases. 
All these data demonstrate the urgent need for novel intervention approaches such as improved 
diagnostic tools and treatment options for canine babesiosis and the development of vaccine 
strategies in order to effectively contain the infection. This PhD thesis was partially funded by the 
“Forschungskredit” of the University of Zurich (grant nos. 55080506 and FK13-053). 
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 Zusammenfassung 
Die drei phylogenetisch verwandten Blutprotozoa der Gattung Babesia, Plasmodium, und 
Theileria sind Verursacher bedeutender human- und veterinärmedizinischer Erkrankungen. Die canine 
Babesiose, eine persistierende endemische Erkrankung in diversen Hundepopulationen, wird durch 
Blutparasiten der Gattung Babesia verursacht. Der Parasit wird durch Zecken übertragen, und seine 
Verbreitung wird durch den internationalen und innerstaatlichen Transport von Hunden sowie durch 
das lokale Vorkommen der Vektorzecken vermittelt. Chronisch subklinische Träger, die folglich 
erschwerte Elimination aller Infektionen, und eine transovarielle Übertragung in der Vektorzecke 
fördern zusätzlich die Verbreitung von neuen Infektionen. 
Babesia canis ist die vorherrschende und klinisch relevante canine Babesia-Art in Europa. 
Obwohl die Pathophysiologie der caninen Babesiose umfangreich erforscht wurde, sind die 
Interaktionen zwischen Parasit und Wirt kaum bekannt. Im Allgemeinen bleibt die periphere 
Parasitämie tief, was jedoch schwere klinische Verläufe und hohe Sterblichkeitsraten nicht verhindert. 
Die pathogenen Eigenschaften von B. canis werden durch sekretierte Faktoren vermittelt, welche 
bisher kaum charakterisiert wurden. Ziel dieser Doktorarbeit ist die Identifizierung von 
Schlüsselfaktoren der akuten B. canis-Infektion, wie etwa das B. canis-Sekretom welches die Biologie 
von infizierten Erythrozyten beeinflusst (Teilprojekt 1), die Beschreibung von klinischen Faktoren und 
pathophysiologischen Mechanismen der Babesiose bei Hunden (Teilprojekt 2), und die Untersuchung 
der Verbreitung von Vektorzecken bei einem lokal begrenzten Ausbruch von B. canis (Teilprojekt 3).  
Wie andere Apicomplexa verfügt B. canis über ein Repertoire von Organellen, ‘’Pathways’’ und 
Strategien, welche sein Überleben in der infizierten Wirtszelle sichern und eine Vermehrung 
ermöglichen. In einem ersten Teilprojekt haben wir für ein besseres Verständnis von spezifischen 
Virulenz- und Pathogenitätsfaktoren das Genom eines virulenten ungarischen B. canis-Stammes 
sequenziert und annotiert. Von den 3467 prognostizierten Genmodellen identifizierten wir 509 
potentielle vom Parasiten sekretierte Proteine. Um eine Reihe von Parasiten-spezifischen 
Proteinkandidaten zu identifizieren welche während der akuten Phase der Erkrankung mitwirken, 
analysierten wird das Proteom und Transkriptom von B. canis-Blutstadien in experimentell infizierten 
Hunden. Unsere Daten deuten auf die Existenz von parasitären Proteinen hin, welche bei der 
Zelladhärenz, Immunevasion und der Umformung der Wirtszelle eine Rolle spielen. Die Kombination 
unserer Analysen liefert eine Liste mit prognostizierten und partiell bestätigten exportierten Faktoren 
von B. canis-Blutstadien, die wahrscheinlich direkt an der Parasit-Wirt-Interaktion während der akuten 
Krankheitsphase beteiligt sind. 
In einem zweiten Teilprojekt fokussierten wir auf Wirtsfaktoren während der akuten B. canis-
Infektion, die mit schwerwiegendem und fatalem klinischen Ausgang assoziiert sind. Wir untersuchten 
28 verschiedene Laborparameter bei 15 natürlich erkrankten Hunden bei deren ersten Vorstellung und 
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vor jeglicher Behandlung, sowie bei 3 experimentell infizierten Hunden während deren 
Krankheitsverlauf. Dabei identifizierten wir 7 prognostische Marker, welche mit schweren 
Krankheitsverläufen assoziiert scheinen. Letztere beinhalten im Allgemeinen eine moderate Anämie, 
schwerwiegende Thrombozytopenie, milde bis moderate Leukopenie, Hyperlaktatämie, moderat 
erhöhtes Serum-Phosphat und erhöhte Triglyzerid-Konzentrationen. Allerdings korreliert die Prognose 
nicht mit klinischen Symptomen oder der Höhe der Parasitämie, welche meist tief bleibt. Die 
veränderten Laborparameter lassen sich nur durch eine übermässige Wirts-Immunantwort mit einer 
Beteiligung von parasiten-induzierten septischen Konditionen erklären. 
In einem dritten Teilprojekt haben wir nach einem Ausbruch einer B. canis-Babesiose im 
Nordosten der Schweiz das Vorkommen der Vektorzecke untersucht. Daten über den Zeckenbefall bei 
Hunden und Katzen sind generell rar. Veränderungen in der lokalen Verbreitung von 
Zeckenpopulationen und die stetige Invasion von Zeckenarten in neue Gebiete gewinnt in Europa 
zunehmend an Wichtigkeit und führt zur stetigen Veränderung der Epidemiologie von Zecken-
übertragenen Krankheiten. Mit einer neuen Beprobungsstrategie in Zusammenarbeit mit Tierbesitzern 
untersuchten wir das lokale Vorkommen verschiedener Zeckenarten auf Hunden und Katzen und 
legten spezielles Augenmerk auf Dermacentor reticulatus, den Vektor der B. canis-Babesiose. Wir 
identifizierten Ixodes ricinus als die häufigste Spezies bei beiden Tierarten, gefolgt von I. hexagonus 
und der B. canis-Vektorzecke D. reticulatus mit Prävalenzen unter 2%. Das lokale Vorkommen von D. 
reticulatus wurde durch flaggen von Zecken in einer moorartigen Umgebung mit offenen Auen, 
wenigen Bäumen und intensiver Sonneneinstrahlung bestätigt. Unsere Beprobungsstrategie führte 
zudem zum erstmaligen Nachweis der Mauszecke I. trianguliceps auf Katzen. Unsere Strategie zeigt 
auf, dass Tierbesitzer zur Erhebung wichtiger epidemiologischer Daten und einer kosteneffizienten 
Zeckenüberwachung beitragen können, und erschafft damit die Basis zur Erforschung lokaler Zecken-
übertragener Krankheiten.  
All diese Daten zeigen den dringenden Bedarf an neuen Interventionsansätzen, wie z.B. die 
Optimierung diagnostischer Werkzeuge, die Verbesserung der Behandlungmöglichkeiten oder die 
Entwicklung von Vakzinestrategien auf, um eine effektive Eindämmung der caninen Babesiose zu 
erreichen. Diese Doktorarbeit wurde teilweise durch den Forschungskredit der Universität Zürich 
finanziert (Projekt-Nr. 55080506 und FK13-053). 
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PART II INTRODUCTION 
 The biology of Babesia canis 
1.1. Babesia and the phylum Apicomplexa 
Babesiosis is caused by an intra-erythrocytic apicomplexan parasite of the genus Babesia which 
is transmitted by ticks. The name honors the Romanian bacteriologist Victor Babes who first described 
a hemolytic disease in sheep and cattle in 1888. Few years later in 1893, the parasitic agent and the 
transmission cycle was discovered by Theobald Smith and Fred Kilborne.1,2 Furthermore, they 
introduced the epidemiological concept of arthropods serving as disease vectors.3 Today, over 100 
Babesia-species have been described, some of which can cause important diseases in domestic 
animals, including pigs, horses, cattle, sheep, goats, cats, and dogs.4 Most species parasitize rodents, 
farm animals, and carnivores. 
The phylum of Apicomplexa is composed of a large group of protozoan parasitic organisms, 
consisting of over 5000 species, and a myriad of unnamed species are estimated to exist.5,6 The 
Apicomplexa are defined by the presence of a conserved apical complex consisting of secretory 
organelles named micronemes and rhoptries and a set of spirally arranged microtubules and conoids 
in some species. Further secretory organelles are present in these protists called dense granules or 
spherical body in the piroplasmids.7,8 Apicomplexan parasites infect a wide range of organisms from 
mollusks to mammals.9 They have a significant economical and medical impact by causing diseases 
affecting veterinary and human medicine. Important diseases include, amongst many others, 
babesiosis (Babesia spp.) in animals and humans, theileriosis (Theileria spp.) in animals, malaria 
(Plasmodium spp.) in humans, and coccidiosis in various forms by Cryptosporidium spp., Isospora spp., 
Eimeria spp., Sarcocystis spp., Toxoplasma gondii, and Neospora caninum. 
There is some discussion about phylogenetic relationships within Apicomplexa (Figure II-1). 
Together with dinoflagellates and the ciliates, the apicomplexans are classified as Alveolata.10,11 Based 
on phenotypic characteristics and organism lifestyle, the Apicomplexa is traditionally arranged in four 
groups: the coccidians, the gregarines, the haemosporidians and the piroplasmids.6 Nevertheless, the 
evolutionary relationships among the four groups and their species are presently unclear and do not 
account modern molecular data.11,12 Besides these groups, there are many small outgroups and species 
forming independent trees, for example the cryptosporidia (which are sometimes classified to a 
separate group of ‘cryptosporidia’ or ‘eimeriorines’). On the other hand, new species were reclassified 
to Apicomplexa, like Nephromyces, an endosymbiotic marine protist.13 This organism was recently 
classified to the haematozoa (syn. Aconoidasida12), to which the order of haemosporidia and 
piroplasms belongs. All these examples show the diversity of the phylum of Apicomplexa. 
PART II     INTRODUCTION 
- 9 - 
 
Figure II-1. Tree of Apicomplexa (adapted and modified 11,14-16). Four traditionally arranged parasitic groups are 
colored differentially (gregarianes, coccidians, haemosporidians, and piroplasmids). Outlying groups, like cryptosporidia, 
which likely emerged from within gregarines, are marked separately. Thickness of branches indicates diversity and numbers 
give a rough estimate of named species. 
 
1.2. Babesia in dogs; development and epidemiology of canine babesiosis 
Canine babesiosis is a clinically significant and geographically widespread hemo-protozoan 
disease of domesticated dogs and wild canids. Like most members of Apicomplexa, Babesia species 
undergo a complex lifecycle, involving asexual and sexual reproduction (Figure II-2). 
Once in the host’s bloodstream, the parasite invades, feeds and replicates within infected red 
blood cells (iRBC) during repeated phases of asexual reproduction (merogony). Reproduction happens 
within few hours after invasion. Lysis of iRBC releases the parasites (merozoites) into the circulation 
which rapidly re-invade red blood cells (RBC). RBC invasion by Babesia is similar to that of many other 
apicomplexan parasites including related human pathogens Plasmodium and Toxoplasma, with 
numerous proteins on the parasite surfaces and within apical secretory organelles mediating the 
complex multi-step invasion process.7 Unlike other apicomplexan parasites such as the close relative 
Plasmodium, intracellular Babesia stages does not reside in a parasitophorous vacuole (PV), which in 
fact disappears within minutes after RBC invasion and leave the parasite directly in the host cell 
cytoplasm.17 When the parasites enter a susceptible tick upon a blood meal, parasites undergo sexual 
reproduction (gamogony), followed by multiple rounds of asexual replication (first schizogony and 
then, sporogony), resulting in numerous sporozoites (in the tick salivary glands) which are infective for 
the next canid host. 
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Babesia species are broadly divided into two phenotypic groups (large and small Babesia), based 
on the relative sizes of the merozoites (3-5 µm for large and 1.5-2.5 µm respectively). Merozoites 
appear round to pear-shaped under the light microscopy (lending piroplasms its name). The different 
species which have been reported in dogs are found in different tick-vector species prevalent in 
different regions (Table II-1). B. canis is the predominant and clinical relevant canine Babesia species 
in Europe. The geographical distribution of B. canis in Europe is largely dependent on the habitat of 
the vector tick species Dermacentor reticulatus. Canine babesiosis in Europe was described for the first 
time from Piana and Galli-Valerio in Italy in 1895.18 Since then, B. canis has spread northwards and 
local transmission could be documented in countries like the Netherlands, Norway and Lithuania.19-21 
An overall presence of canine babesiosis and local differences in the occurrence have been described 
from Spain, Portugal, France, Poland, and Hungary, which are known to be endemic countries, with 
hyper-endemic areas in local parts of the countries.22-24 Furthermore, babesiosis is endemic in parts of 
Germany with a proceeding expansion to new areas.25-27 Contrary to the endemic transmission, in 
other countries the disease is considered as exotic and known as a travel-disease like in the Benelux 
countries, Austria, and Switzerland where low prevalences and focal occurrence are related either to 
imported cases or to small autochthonous foci of B. canis infections.27-29 
 
Table II-1. Characteristics of confirmed canine Babesia species 
 Species Vector Geographic distribution Comments and 
recent references 
small Babesia 
sp. 
Babesia gibsoni Haemaphysalis 
longicornis 
H. bispinosa 
Rhipicephalus 
sanguineus (?) 
Asia, Eastern Europe, 
emerging worldwide 
 
 B. conradae R. sanguineus (?) USA (California) Closely related to 
piroplasms recovered 
from ungulates and 
humans 30 
 B. annae (syn. 
Theileria annae, 
B. vulpes, B. 
microti-like, 
Spanish dog 
isolate) 
I. hexagonus (?) Immunocompromised 
dogs from northern 
Spain, eastern Canada, 
North America 
Parasite was detected 
in foxes in Europe, 
North America, 
Canada 31-34 
large Babesia 
sp. 
B. canis Dermacentor spp. Europe Emerging disease in 
northern and eastern 
countries 
 B. vogeli R. sanguineus Tropical and subtropical 
regions, around 
Mediterranean basin 
 
 B. rossi H. laechii Sub-Saharan Africa and 
Southern Africa 
 
 Babesia sp. 
(North Carolina 
Isolate) 
? East and southeast 
United 
State 
Immunocompromised 
dogs 35,36 
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Figure II-2. General life-cycles of selected apicomplexan species. Simplified lifecycles of apicomplexan parasites are 
pointed out to highlight the differences in host- and cell type specificity. A selection of important hosts is illustrated. (Adapted 
and modified from Heitlinger et al.37) 
 
1.3. Pathophysiology of B. canis infections. 
Following an incubation period of 7 to 21 days after tick exposure, immunologically naïve dogs 
mainly become acutely infected (rarely chronic or per-acute).16,38 In dogs, B. canis cause highly variable 
clinical outcomes from subclinical infections to severe and fatal disease, characterized by hemolytic 
anemia (pale mucous membranes), lethargy, weakness, pigmenturia (dark discoloration of the urine), 
fever, anorexia, vomiting and jaundice.4,39 Although the peripheral parasitemia remains usually low 
(<1% of iRBC), especially the per-acute to acute disease represents an emergency situation with high 
fatality rates.40-44 Based on clinical signs and the outcome of the B. canis infection, at least two different 
groups (sometimes designated as different B. canis strains) have been suggested.44,45 (1) B. canis strains 
inducing often complicated forms, with a high mortality rate (12–20%) in Central- and Eastern Europe 
(mainly Hungary and Croatia 42,44 and (2) B. canis infections showing mainly uncomplicated forms with 
low mortality rates (<5%, the lowest being in France around 1%) in other countries such as Italy, Spain, 
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Portugal, and France.19,22,41,46-50 Such differences in the virulence of B. canis strains strongly suggests 
genetic heterogeneity among B. canis strains (see chapter 1.4.). 
The pathophysiology of B. canis babesiosis is multifactorial and dependent on the immune-
response and age of the host, as well as the involved parasite strain (origin of infection). Diverse 
underlying mechanisms have been discussed to be involved in the B. canis pathophysiology, inducing 
different observable clinical syndromes: 
(1) Anemia is a common observation and the predominant clinical syndrome associated with 
canine babesiosis characterized by intravascular and extravascular hemolysis. The parasitemia does 
not correlate to the proportion of RBC loss. Therefore, additional mechanisms for RBC destruction 
other than mechanical lysis by the release of merozoites have been proposed including immune-
mediated (immune-mediated hemolytic anemia and cytokine reactions), parasite-induced by toxic 
hemolytic factors, and by oxidative stress response.51-54 
(2) Host inflammatory responses (and associated clinical signs) have been shown to be crucial in 
the general pathophysiological mechanisms that underlies babesiosis.55,56 This includes oxidative stress 
with lipid peroxidation and the generation of methemoglobinemia, increased macrophage production 
of superoxide and other reactive oxygen species, acute phase response with RBC aggregation and the 
promotion of vascular stasis, leading to ischemia, thrombosis, and tissue hypoxia and thus, end-organ 
damage. Because the symptoms in babesiosis, like in human malaria caused by P. falciparum, can be 
classified as protozoal sepsis, it was suggested that the inflammatory mechanisms in this disease are 
similar to those of other septic conditions clinically characterized by systemic inflammatory response 
syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Furthermore, documented 
complications include severe thrombocytopenia, disseminated intravascular coagulation (DIC), acute 
renal failure (ARF), hepatopathy, rhabdomyolysis, non-cardiogenic pulmonary edema, CNS 
dysfunction, pancreatitis, systemic hypotension, cardiac dysfunction, hypoglycemia, and metabolic 
acidosis with hyperlactatemia (reviewed in detail in 44,57). 
(3) Hypotensive shock is a frequent complication in canine babesiosis, and can occur at any point 
during the disease process.58-60 Proposed mechanisms include parasite induced activation of potent 
vasodilators and hypotensors, such as bradykinin and kallikrein, and host complement system 
activation of C3a and C5a with resultant vasodilation (relative hypovolemia and drop in blood-
pressure), production of vasoactive proteins (host and parasite), increased capillary permeability, 
decreased intravascular volume, and myocardial depression.58 In turn, hypotension enhances parasite 
sequestration and hypoxia, leading to a vicious cycle of increased disease severity with perpetuated 
inflammation and hypotension.16,61 
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1.4. Diagnosis of B. canis infections 
A tentative clinical diagnosis of acute babesiosis is based on the transmission risk, tick exposure 
and history of travel to an endemic region. However, an accurate clinical diagnosis is difficult because 
clinical signs are mainly unspecific. In acute infections, diagnosis is routinely based on the direct 
demonstration of parasites in Giemsa-stained blood smears allowing a prompt specific diagnosis by 
experienced investigators. In some cases however, morphological diagnosis is made difficult by low 
parasitemia which is commonly observed in subclinical-, latent-, but also in acute infections.40, 41 In 
related canine B. rossi infections, it was demonstrated that the likelihood to detect parasites could be 
increased by capillary smears or buffy coat concentration techniques.4, 62, 63 In order to increase 
sensitivity, detection of B. canis by PCR and other DNA based methods, such as loop mediated 
isothermal amplification (LAMP), have been reported.64-67, increasing the detection limit more than 
hundred times 68 allowing to detect parasites even in small volumes with morphological untraceable 
low parasitemia.69 
To demonstrate parasite exposure, serological antibody detection by immune fluorescence 
antibody test (IFAT) is considered the most specific methodology,70 although the interpretation of the 
results is influenced by the subjective judgement of the operator. Hence, other antibody-detection 
assays have been evaluated, including slide ELISA, sandwich ELISA, competitive ELISA and dot- enzyme 
immunoassay with superior sensitivity but significant lower specificity.71-74 By detecting antibodies, a 
high number of false-negative results was discussed to occur in very young or immunocompromised 
patients, or at acute disease onset, as sero-conversion usually takes 8 to 10 days.75, 76 Limitations are 
also reported in endemic regions, where antibody reactions are not always associated with clinical 
disease.77 Nevertheless, antibody detection assays are beneficial for documenting parasite exposure, 
especially if direct parasite detection fails, or for screening travelers. Furthermore, diagnosis could be 
confirmed by examining paired acute and convalescent sera. Some other techniques including flow 
cytometry based techniques have been developed for the diagnosis of B. canis.54, 70 
 
1.5. Genetic characterization and proteomic background of B. canis 
To date, large Babesia parasites that infect dogs are separated into the three genetically distinct 
species, B. canis, B. rossi, and B. vogeli. Whole genome assemblies of none of these species have been 
published. This is just one reasons why so far not many B. canis genes and proteins have been 
characterized and the genetic and proteomic context of parasite-host interactions is poorly 
understood. 
PCR amplification of the 18S rRNA gene was used to demonstrate the diversity of B. canis strains 
in Poland,49 although the 18S rRNA gene is less suited to study genetic diversity of a given species 
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because it is relatively conserved among strains of a given species.64, 78-80 Genetic variability and 
antigenic variation are important mechanisms for the survival of Babesia parasites in their vertebrate 
hosts. By comparative analysis and hybridization approaches to the major antigenic adhesion protein 
from B. divergens (Bd37), the B. canis Bc28 merozoite surface protein multi-gene family has been 
identified.45, 81 Based on the polymorphism of the Bc28.1 gene, genetic diversity of different B. canis 
strains in Europe has been confirmed. Therefore, based on 18S rRNA gene two different groups were 
described (A and B), and three groups based on Bc28 gene (also A, B, and 34).45 In conclusion, B. canis 
Bc28.1-B strains appear relatively virulent, whereas B. canis Bc28.1-A strains can be either relatively 
virulent if of the 18S rRNA-B genotype or mild if of the 18Sr RNA-A genotype, which is in agreement 
with their previous classification.40, 82, 83 
Substantial progress in B. canis protein characterization origin from vaccine research. Since 
decades it is known that a crude soluble parasite antigen (SPA) from blood culture supernatant of 
several Babesia species can be used as a vaccine against the clinical manifestation of babesiosis 
challenged with the same parasite strain.84-86 Furthermore, classical historical experiments showed 
that the plasma of infected animals can protect healthy animals from a challenge infection.87 Proteins 
from the SPA fraction containing also glycoproteins are highly immunogenic.88, 89 Nevertheless, the 
composition of secreted B. canis proteins in the supernatants of blood cultures is largely unknown. 
On the proteomic level, Bc28.1 and Bc28.2 proteins from the Bc28 family are some of the few 
characterized proteins in B. canis. The small RBC binding protein Bc28.1 is a major antigen on the 
surface of B. canis merozoites. The gene encodes a 28 kDa GPI-anchored protein. By antibody-
detection approaches, a localization of the Bc28 proteins on the parasites surface, on the host cell 
membrane and secreted extracellular to the host could be demonstrated.90 The function of Bc28.1 and 
Bc28.2, the only cloned and sequenced members of this family, are still unknown. It is proposed that 
these antigens play a critical role in the initial attachment of merozoites to the RBC membrane during 
the invasion process.91 Comparison of the two genes (Bc28.1 and Bc28.2) and predicted amino acid 
sequences demonstrates highly conserved N-terminal regions, and C-terminal regions that are 
divergent. As a consequence, the GPI-anchor that is present in Bc28.1 is not predicted in Bc28.2.81 
Recently, a complementary DNA expression library was used to screen antigens for novel sero-
diagnostic techniques for the detection of B. canis infections.92 This approach resulted in the 
description of a merozoite surface antigen (BcMSA1) and a secreted protein (BcSA1) as potential 
diagnostic antigen candidates. Polyclonal mouse sera raised against recombinant forms of these two 
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proteins and confocal microscopic observations with B. canis iRBC revealed that BcMSA1 and BcSA1 
locate on the surface of the parasites, whereas BcSA1 is also located cytosolic. 
By aiming to discover other vaccine candidates, an extrachromosomal dsRNA-encoded protein 
(Bcvir15) with putative functions in intracellular growth of the parasite has been described.93 Whether 
this gene is derived from a virus or from other apicomplexan organelles harboring DNA (mitochondria, 
apicoplast) has not been further investigated to date. 
 Parasite-host interaction – insights from related apicomplexan organisms 
How Babesia, which are tiny pathogens and should be kept in check by the host, manage to 
survive lies within a large number of secreted- and surface-associated factors that transform infected 
host cell, and that are major players in parasite-host interaction, virulence, and pathogenicity. In this 
respect, apicomplexan parasites have developed a repertoire of organelles, strategies and pathways. 
This includes factors secreted in a coordinated and sequential manner during the complex multi-step 
invasion process, modulated by specific secretory organelles (micronemes, rhoptries, and dense 
granules/spherical bodies) which are shared amongst apicomplexan parasites. This is well described in 
the ubiquitous zoonotic and well-studied apicomplexan Toxoplasma gondii,94, 95 in Plasmodium spp.,96, 
97 and in bovine Babesia spp.98-101 In order to translocate and communicate through different 
membranes (from parasite and host), intracellular parasites evolved the ability to remodel and modify 
the infected host cell. For example, Plasmodium spp. and B. bovis alter the infected host cell to 
generate an endothelial adhesive phenotype and sequester to escape degradation by the host defense 
system.102-104 This active remodeling requires export of parasite proteins into the host cell cytoplasm 
and beyond with direct interaction with the host proteome.105 
 
2.1. Secretory organelles in apicomplexan parasites 
As a condition for adaption to diverse niches and hosts, apicomplexan parasites have evolved 
characteristic organelles and other ultrastructural features (see figure II-3). Secretory organelles 
consisting of micronemes, rhoptries and dense granules (‘spherical bodies’ in Babesia). Whereas the 
micronemes and rhoptries, both, are located and secrete their content at the apical tip of the parasite, 
the dense granules are not necessarily located apically and their proteins function in the PV, 
parasitophorous vacuolar membrane (PVM), or in tubular networks, depending on the stage and 
species.106-108 Because of their specialized nature, the majority of proteins secreted from these 
organelles are unique to apicomplexan parasites and interesting targets for vaccine, drug and 
diagnostic development.109 
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2.1.1. Micronemes 
The micronemes contain proteins (MICs) that are involved in the attachment of parasites to the 
host cell surface,110 and in the formation of a connection to the host cell including the parasite 
actinomyosin motor,111 which drives motility and invasion.112 Several parasite adhesins that bind to the 
appropriate receptors on the host cell have been identified, which are highly diverse between different 
species due to co-evolution with different hosts and host cell receptors.113, 114 Gliding of the parasite 
and movement through tissues is supported by proteases embedded in the basal end of the plasma 
membrane resulting in the shedding of the parasite ligands from the surface.115, 116 Some microneme 
proteins are conserved between all apicomplexans, such as apical membrane antigens (like AMA-1 
protein) that is thought to trigger further rhoptry release.99, 117, 118 Notably, recent studies have 
highlighted the roles of MICs (TgMIC8 in T. gondii; PfEBA175 and PfAMA1 in P. falciparum) facilitating 
the secretion of rhoptry contents.119-122 Besides invasion, a pore-forming protein released from the 
micronemes has been identified to be involved in host cell egress in T. gondii tachyzoites.123 
2.1.2. Rhoptries 
After invasion, rhoptry proteins are instrumental in the formation of the PVM.124, 125 Different 
studies suggest that the rhoptry neck and rhoptry bulb are two distinct compartments, which contain 
different proteins, and are released differentially. For instance, the RON proteins stored in the rhoptry 
neck are critical for the formation of the tight junction between the parasite and the host cell, and 
therefore are important for host cell invasion. Rhoptry bulb proteins (ROPs) function predominantly 
downstream of invasion in modifying the vacuolar membrane and the host cell enhancing parasite 
survival within the cell.7, 8, 109, 118, 126, 127 For example, some rhoptry kinases in T. gondii, which have been 
characterized in detail, are key modulators in virulence and host response.128-130 Nevertheless, the 
biological functions of many rhoptry proteins remain largely unknown, owing to the lack of appropriate 
and robust methods to study essential parasite proteins although genetic manipulation strategies in 
cultivable species exist.131, 132 
2.1.3. Dense granules / spherical bodies 
The content of dense granules (spherical bodies in Babesia) is released immediately and 
constitutively after invasion.8 The proteins of this organelle modify the host cell and structures to 
generate parasites own habitat.7, 125, 133, 134 The spherical body proteins (SBP) found in Babesia and 
Theileria are considered to perform comparable functions to the dense granules found in other 
apicomplexan parasites. Nevertheless, no distinct function has yet been ascribed to any of these 
proteins. Over the last 20 years, four proteins have been identified which localize to these organelles 
termed SBP1, 2, 3, and 4.135-138 Interestingly, none of the SBPs show any significant homology to any 
other known proteins.137 One feasible possibility is that they are involved, either directly or indirectly, 
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in the formation of ridges on iRBCs, a function consistent with their demonstrated cellular localization 
at the iRBC membrane,7 suggesting also an important role in parasite virulence.139 
 
 
Figure II-3. Schematic picture of a Babesia merozoite. 
 
2.2. Protein trafficking in the intra-erythrocytic apicomplexans Plasmodium and Babesia 
Both Babesia and Plasmodium invade and replicate within RBCs. As mature RBCs lack any de 
novo protein synthesis and also have no trafficking pathways, the parasite has to bring along its own 
biochemical facilities. In Plasmodium it has been described that parasites induce new pathways that 
increase iRBC plasma membrane permeability to allow the uptake of nutrients and the removal of 
waste products, to avoid the host immune system and to escape destruction by the spleen.99, 140-143 
During the invasion process, the parasite forms a surrounding membrane in which it resides, the PVM. 
However, a fundamental difference between Plasmodium and Babesia is the maintenance of the PVM, 
which is present throughout the developmental cycle in Plasmodium, but in Babesia disappears within 
minutes after invasion leaving the parasite directly in the host cell cytoplasm.17 Regardless of the fate 
of the PVM, the parasite has to have the capacity to secrete factors into the host cell to modify, create 
or modulate host cell functions, to suit the needs of the parasite. Hence, the parasite needs to create 
an export machinery. 
In Plasmodium, a functional domain required for the export of parasite proteins into the host 
cell has been defined, termed Plasmodium host targeting (HT) motif or export element (PEXEL) for 
trafficking beyond the PVM.144, 145 Furthermore, a second group of exported proteins does not contain 
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a PEXEL (so called PEXEL negative export protein, PNEP) but include other shared signals like essential 
transmembrane (TM) domains.146, 147 Translocation of soluble PEXEL and PNEP proteins into the host 
cell is mediated via an ATP-driven translocon (Plasmodium translocon of exported proteins ‘PTEX’).131, 
147 Although a PVM translocon is a supposable gate for soluble proteins, it is unclear how TM proteins 
fit into this model. 
PEXEL motifs were initially found to be absent in the predicted B. bovis exportome.148 
Comprehensive comparative in silico analysis of protein export in different apicomplexan species 
revealed PEXEL-like motifs (PLM) in B. bovis (but not in Theileria parva) involved in retaining proteins 
within spherical bodies and releasing their contents in a cell- cycle dependent manner.149 
Plasmodium and Babesia both show expansion of large membrane-bound proteins transported 
to the cell surface: the variant PfEMP1 (erythrocyte membrane protein) in P. falciparum 150 and the 
variant VESA1 (variant erythrocyte surface antigen) in Babesia.151 Members of both protein families 
share common features: many proteins lack classical N-terminal signal peptides for ER-targeting, but 
often contain internal TM domains. In both cases, orientation and mode of translocation remain 
unclear. Therefore, some kind of alternative non-classical secretion pathway could be present which 
yet has to be described.147, 149 
 
2.3. Immune evasion and antigenic variation – strategies to escape host defense 
In order to avoid splenic passage, some Plasmodium and Babesia species have evolved strategies 
for cytoadhesion and sequestration of iRBC to escape host immune defense, allowing to establish a 
persistent infection. This characteristic phenotype has been described in P. falciparum,152 P. 
chabaudi,153 P. knowlesi,154 B. bovis,151 B. bigemina,155, 156 B. canis 157 and potentially B. duncani,158 
although the extent and structural basis likely differ among species. Furthermore, auto-agglutination 
of iRBC or agglutination to non-infected RBC (rosetting) have been observed. 
Responsible for the adhesive phenotype in P. falciparum and B. bovis are mainly the 
immunovariant adhesins P. falciparum EMP1 (erythrocyte membrane protein 1) and the heterodimeric 
B. bovis VESA1 (variant erythrocyte surface antigen 1).152, 159 Another benefit of the cytoadherence may 
also be a diminished access to circulating cells of the immune system.160 
A close relationship of these variant adhesins to antigenic variation has been demonstrated.161 
Clonal antigenic variation of surface membrane proteins (i.e. to generate unique and changing B-cell 
epitopes) by protozoan parasites enables to avoid host immune responses and thus perpetuate long-
term infections. 
At the genetic level, the responsible genes in P. falciparum (e.g. var-genes) and B. bovis (ves1-
genes) differ in structure and sequence. The increased genetic variation of the B. bovis ves1 gene family 
compared with the P. falciparum var gene family might result in a greater number of B. bovis strains 
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capable of evading the host immune system.141, 162 Somatic recombination of gene segments from 
inactive ves genes into an actively transcribed locus allows the parasite to generate a potentially 
limitless repertoire of surface antigens, although overall evidence that every combination results in 
functional adhesive properties is missing.163, 164 
In P. falciparum, additional surface proteins have been identified, including stevor, sequestrin, 
surfin, Pfmc-2TM, and the rifins.141, 165 Further strategies of Babesia to escape host defense could be 
mediated by parasite proteins triggering anti-inflammatory cytokine release.166 Altogether, Babesia 
parasites harbor an arsenal of factors for parasite-host interactions, which are far from being 
completely explored. 
 The framework of apicomplexan genomes 
Genome assembly and annotation of intracellular apicomplexan parasites is challenging, 
because it is often difficult or impossible to generate appropriate genomic material by maintaining live 
and reproductive in vitro parasite cultures, in particular appropriate for Babesia species. Nevertheless, 
whole genome sequences of several parasites in the apicomplexan phylum have been published. This 
genomic information is predominantly collected and maintained by the EuPathDB 
(http://eupathdb.org) including 11 specialized resources for different apicomplexan species.167 
The genome of several species in the triad of apicomplexan hemo-parasites (Babesia, 
Plasmodium and Theileria) have been made available. P. falciparum was the first apicomplexan 
genome to be sequenced,168 followed by the sequencing efforts of many more species, including 
several other Plasmodium, Babesia and Theileria species (Table II-2). 
Structurally, the genomes are organized in 4 to 14 linear chromosomes each with a centomeric 
and subtelomeric region, and telomeres. Plasmodium species have fourteen chromosomes of variable 
lengths.168 On the other hand, Theileria sp. (T. annulata and T. parva) and Babesia sp. (B. bovis and B. 
bigemina) have four chromosomes.164, 169-171 Genome features from available hematozoa are 
summarized in Table II-2. It is important to note that these genomes, although published, contain 
physical gaps and misannotated genes.172 Most parasites in the apicomplexan lineage show two 
organelles with their own extrachromosomal DNA, the mitochondrion and the apicoplast. The 
apicoplast is an essential organelle in most apicomplexan (only in the genus Cryptosporidium an 
apicoplast is missing, which probably has been lost secondarily).173 The functions of the apicoplast have 
not been exclusively figured out, but the apicoplast seems to play a role in fatty acid, isoprenoid, and 
iron-sulfur cluster synthesis, and co-opts with the mitochondrion in the heme synthesis and 
processing.174-177 
Comparison and alignments of whole genomes reveal a high level of synteny within single 
hematozoan families (e.g. among Plasmodium species). Interestingly, extensive synteny was identified 
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between Theileria and Babesia species, accounting for shared phylogenies. Only limited orthology 
could be identified between B. bovis and P. falciparum, although there are shared clinical and 
pathological characteristics.178, 179 (For graphical representation see Kissinger et al.179) 
A feature of parasite genomes is gene loss compared to their free-living relatives directly related 
to their parasitic lifestyle.178, 180, 181 Hence, comparative functional analysis of apicomplexans 
proteomes shows many common features but also clear differences to free-living eukaryotes with 
similar genome size. There is a number of proteins that markedly differ, which are important for 
parasitic adaptations.182 Therefore, these unique parasite genes which codes for various secreted, cell-
surface, transmembrane and membrane-anchored proteins at the parasite-host interface are of 
special interest as ideal targets for new intervention approaches (like novel diagnostic tools, vaccines 
and therapeutics). 
 
Table II-2. Summary of intra-erythrocytic apicomplexan genome sequence projects 
Organism 
Genome size 
(Mbp) 
Number of 
chromosomes 
Number of 
predicted 
genes 
G+C 
content 
(%) 
Reference 
(year of first publication) 
Plasmodium      
P. berghei ANKA 18.78 14 5254 22.1 (2005)183-185 
P. chabaudi chabaudi 18.97 14 5364 23.6 (2005)183, 185 
P. coatneyi Hackeri 27.81 - - - (2014)b 
P. cynomolgi strain B 26.18 14 5776 40.4 (2012)186 
P. falciparum 3D7 23.33 14 5777 19.4 (2002)168 
P. falciparum IT 22.98 14 5699 - (in preparation)c 
P. gallinaceum 8A 16.93 - - - (2006)b 
P. knowlesi strain H 24.40 14 5483 38.8 (2008)187 
P. reichenowi CDC 23.92 14 6069 19.27 (2014)185 
P. vivax Sal-1 27.01 14 5626 42.3 (2008)188 
P. yoelii yoelii 17X 22.76 14 6102 - (2014)185 
P. yoelii yoelii 17XNL 22.94 - 7774 22.6 (2002)189 
P. yoelii yoelii YM 22.03 14 5833 21.1 (2014)185 
      
Babesia      
B. bigemina strain BOND 13.84 4 5125 51 (2014)164 
B. bovis T2Bo 8.18 4 3781 41.5 (2007)171 
B. bovis C9.1a 7.61  3726 42 (2014)164 
B. microti strain RI 6.39 4 3554 36 (2012)190 
B. divergens. 1802Aa 9.58 4 4134 42 (2014)164 
B. divergens Rouen1987a 8.97 4 4097 46 (2014)164 
      
Theileria      
T. annulata strain Ankara 8.36 4 3845 32.5 (2005)170 
T. equi strain WA 11.67 4 5397 39.5 (2012)191 
T. orientalis strain 
Shintoku 
9.01 4 4058 - (2012)b 
T. parva strain Muguga 8.35 4 4167 34.1 (2005)169 
      
Cytauxzoon      
C. felis strain Winnie 9.11 - 4389 31.8 (2013)192 
 
adata not available in EuPathDB 
bdata uploaded to EuPathDB (release 26). No publication available 
cdata available from Welcome Trust Sanger Institute. Manuscript in preparation 
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 Aims of the thesis 
Canine babesiosis is considered an emerging vector-borne disease, as numerous cases have 
been reported globally and in new areas throughout Europe including focal regions in Switzerland. 
Currently, host-parasite interactions in B. canis babesiosis are poorly understood. Hence, a significant 
improvement of our knowledge about the molecular details of the infection process and 
pathophysiology is required as a prerequisite for new intervention approaches.  
Based on comparative data with related apicomplexan parasites we hypothesized that parasite-
specific secreted factors are key determinants of pathogenicity inducing severe symptoms in infected 
dogs. Hence, the primary goal of my thesis was to identify and analyze the secreted B. canis proteome 
which affects iRBC biology and host response. In order to enhance our background knowledge about 
B. canis infection biology, objective was to investigate epidemiological aspects, to study 
clinical/pathological symptoms in canine babesiosis and to establish parasite genomic-, transcriptomic 
and proteomic resources. The project was funded by the “Forschungskredit” of the University of Zurich 
(grant nos. 55080506 and FK13-053) and contributes towards the development of novel diagnostic 
tools. 
 
The following research questions were addressed. 
i) Molecular pathophysiology. What is the composition of the secretome of a virulent 
Babesia canis strain on a genomic and proteomic level? Which are the molecular 
parasite components during acute virulent B. canis infection? Which secreted 
soluble and host membrane-bound proteins from blood-stage parasites are 
involved in parasite-host interactions? 
ii) Clinical pathophysiology. Are there different measurable prognostic markers (host 
factors) associated with poor outcomes in acute B. canis infections? 
iii) Tick vector occurrence following an outbreak of B. canis. Is a pet-owner based tick 
sampling strategy applicable as a systematic and cost-effective sampling method to 
detect the tick vector for B. canis in an emerging epidemiological region? Which tick 
species are parasitizing companion animals? 
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 General remarks 
The thesis includes three first author manuscripts, of which two were printed in peer-reviewed 
journals and one is in preparation for being submitted. In addition, contribution toward novel 
diagnostic tools resulted in the generation of two monoclonal antibodies with diagnostic potential. All 
performed work would not have been possible without the fruitful collaboration and contributions by 
the co-authors and acknowledged persons. The data from this thesis contributed toward the 
evaluation of a patent announcement in collaboration with the technology transfer organization from 
the University of Zurich ‘Unitectra’ and industrial partners. 
Chapter 2.1. is the first draft of the manuscript on the molecular characteristics presented during 
acute and virulent B. canis infection. This study represents the main part of my PhD work. Substantial 
proportion of this work including generation of biological material, evaluation and optimization of 
protocols, laboratorial and bioinformatics work as well as analysis and interpretation of the results was 
performed by me, in collaboration with Dr. Chandra Ramakrishnan (transcriptomics) and supervised 
by Prof. Adrian B. Hehl. Fundamental part for the success of this work consisted of the challenging 
animal experiments supervised intensely by Prof. Peter Deplazes. Genome assembly and annotation 
was assisted by Dr. Giancarlo Russo (Functional Genomics Center Zurich). The manuscript draft was 
mainly written by me and Prof. A.B. Hehl and will be improved by few additional data. 
Chapter 2.2. is the published manuscript in ‘Journal of Veterinary Internal Medicine’ with the 
title “Prognostic markers in acute Babesia canis infections”. This clinical orientated work evaluated 
prognostic markers associated with poor outcomes in acute infections and gives insights into the 
pathophysiology of canine babesiosis. Supervised by Prof. Peter Deplazes and assisted by the Clinical 
Laboratory from the Vetsuisse Faculty, University of Zurich (UZH), I examined and analyzed clinical 
cases and samples from the Clinic for Small Animal Internal Medicine (UZH), private practices and 
experimental inoculated dogs. I was substantially involved in the design of this work and performed all 
the included animal experiments. All authors contributed in drafting the manuscript. 
Chapter 2.3. corresponds to the published manuscript in ‘Ticks and Tick-borne Diseases’ with 
the title “Ticks on dogs and cats: A pet owner-based survey in a rural town in northeastern 
Switzerland”. This survey demonstrated a simple and cost-effective method for sampling vector-ticsk 
verified by standard tick-flagging techniques and identified a so far unknown focus of the vector-tick 
in an area with increased incidence of B. canis babesiosis. The project idea, designs, and strategies 
were developed by Prof. Peter Deplazes and me, and was further supervised by Prof. Alexander Mathis 
from the Institute of Parasitology (UZH). I performed the morphological and molecular tick 
identifications, carried out the field investigations, and conducted the statistical analyses. All authors 
contributed in drafting the manuscript.  
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2.1. Combined analysis of the Babesia canis genome, transcriptome and secreted 
proteome during virulent infection identifies potential pathogenicity factors 
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Abstract 
Infections of dogs with virulent strains of Babesia canis are characterized by rapid onset and high 
mortality, comparable to complicated human malaria. As in other apicomplexan parasites, most 
Babesia virulence factors responsible for survival and pathogenicity are secreted to the host cell 
surface and beyond where they remodel and biochemically modify the infected cell and interact with 
host proteins in a very specific manner. Here, we investigated factors secreted by B. canis during acute 
infections in dogs and report on in silico predictions and experimental analysis of the parasite’s 
exportome. As a backdrop, we generated a fully annotated B. canis reference genome sequence of a 
virulent Hungarian field isolate (strain BcH-CHIPZ) underpinned by extensive genome-wide RNA-seq 
analysis. We find evidence for conserved factors in apicomplexan hemoparasites involved in immune-
evasion (e.g. VESA-protein family), proteins secreted across the iRBC membrane into the host 
bloodstream (e.g. SA- and Bc28 protein families), potential moonlighting proteins (e.g. profilin and 
histones), and uncharacterized antigens present during acute crisis in dogs. The combined data 
provides a first predicted and partially validated set of potential virulence factors exported during fatal 
infections, which can be exploited for urgently needed innovative intervention strategies facilitating 
diagnosis and management of acute and chronic canine babesiosis. 
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Introduction 
Apicomplexan parasites have evolved a plethora of targeted interactions with their host organisms and 
cellular machinery to elicit modification of gene expression and cellular functions. These modifications 
are critical for invasion and optimizing intracellular niches for replication, differentiation, and 
persistence, while securing nutrient import and mediating immune evasion (Goldberg and Cowman 
2010). As a result, host-parasite relationships in Apicomplexa can be viewed as co-adaptations driven 
by co-evolution of parasites with their hosts (Morrison 2009). Most importantly, this complex interplay 
is directly linked to pathogenicity and virulence which characterize symptomatic infections with these 
protozoan parasites (Bradley and Sibley 2007; Haldar and Mohandas 2007; Hutchings et al. 2007; Maier 
et al. 2008; Lobo et al. 2012; Singh et al. 2014). 
Three genera of this phylum represent a triad of phylogenetically related hemoprotozoa: Plasmodium 
(human and animal malaria), Theileria (theileriosis in livestock), and Babesia (severe disease and death 
in cattle, horses, dogs, with some zoonotic potential) are the causative agents of important human 
and/or animal diseases with high morbidity and mortality, responsible for significant economic 
burdens and healthcare challenges worldwide (Lau 2009). The clinically relevant part of the complex 
Babesia life cycle that involves tick vectors in addition to mammalian hosts takes place during asexual 
proliferation of parasites in red blood cells (RBC). This represents a distinct specialization of Babesia 
for life in mammalian erythrocytes, i.e. cells which lack organelles, as well as endocytic and exocytic 
membrane transport machinery (Gohil et al. 2010; Spielmann and Gilberger 2015). 
Canine babesiosis is an emerging tick-borne disease of dogs with global distribution caused by 
morphologically distinctive Babesia species (Schetters et al. 1997; Boozer and Macintire 2003; Irwin 
2009). The distribution of disease caused by B. canis, the species responsible for a virulent form of 
canine babesiosis in Europe and Western Asia, appears to spread northward, as demonstrated by an 
increasing numbers of cases in areas outside of classical endemic regions (Halos et al. 2014). The 
clinical spectrum of symptomatic B. canis disease is broad, ranging from apparently silent and mild 
infections to fulminant and often fatal, human malaria-like presentation (Irwin 2009). Indeed, in many 
respects canine babesiosis can serve as model for clinical human malaria (Reyers et al. 1998; Schetters 
and Eling 1999). Reports from Central and Eastern Europe (e.g. Hungary) indicated a high incidence of 
canine babesiosis with severe symptoms and high mortality rates (12 – 20%), whilst uncomplicated 
forms with mortality rates below 5% prevail in Southern and Western European countries (Italy, Spain, 
Portugal, Netherlands, France) (Furlanello et al. 2005; Bourdoiseau 2006; Mathe et al. 2006; Ruiz de 
Gopegui et al. 2007; Solano-Gallego et al. 2008; René-Martellet et al. 2013). This suggested genetic 
heterogeneity within the B. canis population structure (Carcy et al. 2015) which was further supported 
by reduced to absent cross-immunity in vaccination trials with soluble parasite antigen (SPA) extracts 
prepared from isolates with different geographic origins (Schetters 2005). In addition, severe side 
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effects with SPA formulations suggested the presence of highly pathogenic factors in many of these 
uncharacterized crude fractions (Adaszek et al. 2012). However, the nature of these soluble virulence 
factors which are suspected to cause severe pathogenesis in natural infections of dogs remains 
unknown. 
Analysis of correlated genomic, transcriptomic and proteomic data provides the molecular 
underpinnings for investigating the role of exported factors in disease manifestation and progression. 
However, experimental investigation of B. canis biology is severely limited by the current lack of 
cultivation techniques for parasite propagation in vitro. Here, we implemented short term in vitro 
cultivation of infected RBC in combination with genome sequencing, annotation, and comparative 
genomic characterization of a virulent Hungarian B. canis field isolate. By correlating RNA-seq and 
protein mass-spectrometry data, we provide the first account of factors exported by B. canis blood 
stages with potential links to host-pathogen interaction and acute virulence. 
 
Results 
Genome sequence of a virulent Babesia canis strain 
Until recently, only few genes from canine Babesia species have been characterized and global 
genomic data were not available. To provide the molecular underpinnings for targeted approaches to 
diagnosis, vaccination and clinical management of canine babesiosis we undertook complete 
sequencing, assembly, annotation and characterization of the genome of a virulent B. canis strain, 
designated BcH-CHIPZ. The BcH-CHIPZ isolate originated from the blood of a Swiss dog that was 
infected, presumably through the bite of an infected tick, during a trip to Hungary. The isolate was 
characterized by genotyping and identified as double B-type by restriction site analysis in the Bc28-
multigene family and the 18SrRNA gene (Carcy et al. 2015). We implemented a next-generation high 
throughput approach (PacBio® SMRT) for sequencing of BcH-CHIPZ genomic DNA prepared after 
enrichment of infected RBC (iRBC). Assembly of the parasite-specific sequence reads after elimination 
of all reads from host DNA and gap-filling yielded 43 high-quality scaffolds covering a total of 7’002’180 
bases with a median weighted contig size (N50) of 185 kb. Hence, the calculated size of the B. canis 
genome lies between the phylogenetically related B. microti (6.5 Mb) and the B. bovis (8.2 Mb) 
genomes (Brayton et al. 2007; Cornillot et al. 2012). The main features of the annotated B. canis 
genome and a comparison with other apicomplexan genomes are presented in Table 1. The quality of 
the genome assembly based on the presence of core eukaryotic genes (Parra et al. 2007; Reid et al. 
2014) indicates the B. canis genome sequence to be 92.6% complete. This is comparable with the 
genome of the T. gondii ME49 type II reference strain (Gajria et al. 2008) and consistent with values of 
other Babesia genome sequences, which lie between 91.7% and 95.6% (Supplemental_Document_S1). 
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This robust annotation of species-specific gene models was based on the analysis of orthologues and 
synteny in related species (described below). Furthermore, the B. canis scaffolds could be contiguously 
aligned to the 4 chromosomes of the related B. bovis by a whole genome mapping approach. This 
suggested a strong syntenic relationship with chromosomes of B. bovis (Fig. 1). 
 
Genome-wide comparison of B. canis gene models with those of other Apicomplexa reveals species-
specific genes 
The B. canis gene models were analyzed for orthologues in four representative apicomplexan parasites 
B. bovis, Th. annulata, P. falciparum, and T. gondii and the fully sequenced Babesia species B. bovis, B. 
bigemina, and B. microti by clustering of orthologous groups using a Markov Cluster algorithm in 
OrthoMCL (Fig. 2). All four Babesia species share a core set of 1216 conserved orthologous clusters, 
even allowing for the smaller number of gene models in B. canis. However, comparison of bovine and 
rodent Babesia gene models revealed 1030 shared OrthoMCL clusters which are not represented in 
the B. canis genome, which comprise a higher than average proportion (75.7%) of hypothetical, 
putative, or uncharacterized genes (Supplemental Data S1, S2). We take this comparatively smaller 
and more diverged set of annotated genes in B. canis as a reflection of the narrow and highly specific 
host range in vertebrates and ticks. This interpretation is based on the premise that the diversity of 
encoded proteins is linked to the degree of specialization for different environments, niches, and 
lifestyles of a parasite, thus reflecting lineage-specific adaptations (Templeton et al. 2004; Heitlinger 
et al. 2014). Therefore, the divergent and less redundant (smaller) gene set may represent the 
comparatively narrow vertebrate and arthropod host range of B. canis. Interestingly, with 347 
genes/Mb the B. canis genome has a similar gene density as the B. bovis (372 genes/Mb) and B. microti 
(354 genes/Mb) genomes, although some regions appear to be more densely packed than others (Fig. 
1). 
Analysis of orthologues revealed a high degree of synteny between the genomes of B. canis and B. 
bovis compared with the genome of rodent B. microti (Fig. 1). 
 
Analysis of mRNA expression and prediction of the B. canis exportome 
Exported proteins of apicomplexan parasites include virulence factors, i.e. parasite-specific proteins 
which interfere directly with host cell functions. As mature RBC lack de novo protein synthesis or 
trafficking pathways, membrane transport machinery for targeting these proteins via the cytoplasm to 
the iRBC surface and beyond are provided by the parasite. These parasite-induced cytoplasmic 
alterations of iRBC are critical for its development and directly linked to the severity of babesiosis 
(Pedroni et al. 2013). As a first step to characterize parasite-secreted factors and surface proteins, we 
generated a predicted B. canis exportome based on the annotated BcH-CHIPZ genome. We used data 
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mining tools to search for genes coding for predicted parasite surface and iRBC targeted factors. The 
criteria and prioritization for this selection were based on the presence of a canonical hydrophobic N-
terminal signal peptide (cSP) sequence, an alternative secretion pathway (a/ncSP) signal used by non-
classical protein secretion, predicted transmembrane (TM) domain(s), a GPI anchor signal, or 
previously described domains of conserved apicomplexan secretory proteins and protein families (for 
details see Materials and Methods section; Supplemental Fig. 1; Supplemental Data S3). By this 
approach we generated a curated and parsed list of 509 predicted proteins exported to the parasite 
surface and/or to the host, which corresponds to 14.6% of all gene models (Fig. 3A). This proportion is 
very similar to the 528 gene models (14%) representing the predicted B. bovis secretome (Pelle et al. 
2015). 
All apicomplexan parasites express members of gene families that are exported to the surface of 
invasive stages or the plasma membrane of iRBC where they interact with the host immune system 
(Spence et al. 2013). Members of the Babesia variant erythrocyte surface antigen (VESA) family on the 
surface of iRBC (Allred et al. 1993) comprise the largest protein family in B. canis (103 gene models) in 
the predicted exportome (Fig. 3B). Most VESA genes cluster together on few contigs (Fig. 1), unlike 
other gene families of the predicted exportome which are distributed more randomly. Furthermore, 
VESA genes are in regions with high gene density, consistent with frequent gene duplication events by 
a driving selection pressure on these proteins associated with immune-evasion. MSA, B. canis 
merozoite surface-exposed, plasma membrane-anchored proteins (2 gene models in B. canis), as well 
as Bc28 family members (20 gene models), are highly abundant on the merozoite surface but are also 
shed and interact with the iRBC membrane and the host’s immune system (Yang et al. 2012; Zhou et 
al. 2016). The second-largest family of exported proteins comprises secreted DnaJ (Hsp40) chaperones 
(26 members). P. falciparum DnaJ proteins have a demonstrated role in remodeling of iRBC and in 
pathogenesis among other functions (Rug and Maier 2011; Njunge et al. 2013). The so-called “secreted 
antigens” (SA-1 and SA-3, 24 members) comprise yet another family of genes coding for exported 
proteins. PBlast analysis showed that the B. canis SAs are highly homologous (23 of 25 proteins with 
e-values <10E-5) to those of B. gibsoni, which also propagates in dogs, and to a lesser extent to SAs of 
B. bigemina (3 of 25 proteins with e-values <10E-5), which infects bovines, suggesting that host-specific 
factors drive expansion and diversification of these orthologous gene families. In contrast, genes 
coding for smORF and spherical body proteins (SBP) appear to be specific to B. bovis and are without 
orthologues in the B. canis genome (Jackson et al. 2014; Pelle et al. 2015). Proteins of the “secreted 
antigen family”, as the name indicates, are secreted beyond the iRBC and circulate in the blood of 
infected dogs but are otherwise not well characterized (Zhou et al. 2016). The predicted B. canis 
exportome also includes a group of 23 protein kinases. Of note, among the group of secreted protein 
kinases and pseudokinases are key virulence factors in toxoplasmosis (Saeij et al. 2007; Steinfeldt et 
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al. 2010; Fleckenstein et al. 2012; Etheridge et al. 2014). Kinases are also secreted into iRBCs in 
Plasmodium, where they are responsible inter alia for remodeling the host cell (Saeij et al. 2006; Lim 
et al. 2012). However, functional data related to secreted kinases in Babesia are not available. 
Nevertheless, kinase inhibitors have been identified as potential novel drugs for the treatment of 
babesiosis in cattle (Bork et al. 2006; Pedroni et al. 2016). 
To refine the predicted host-targeted B. canis exportome dataset we analyzed the transcript levels of 
all selected 509 gene models in parasites harvested from a splenectomized dog. Evidence from a 
genome-wide RNAseq analysis showed transcription of 71.5% of the 509 exportome gene models 
(FPKM > 10; n=364) (Fig. 4A). Remarkably, only a few members each of the five most abundant 
exported protein family genes (VESA-, DnaJ-, SA-, PK-, and Bc28- multigene families) with potential 
roles in antigenic variation and immune evasion were expressed at high levels (FPKM > 1000) (Fig. 4B-
F). The particular expression profile of the five gene families in this snapshot might be due to selection 
of a few specific phenotypes in the population at the peak of pathogenicity, but one should also 
consider that the collected blood stage parasites do not represent a synchronously developing 
population. Nevertheless, this finding merits further investigation, in particular in the light of previous 
observations indicating that pathogenicity was associated with expression of a specific subset of VESA- 
and other exported genes in B. bovis infection (Pedroni et al. 2013). 
Further in silico characterization of the predicted B. canis exportome revealed a significant number of 
proteins (210/509) lacking a canonical hydrophobic signal sequence for co-translational insertion into 
the endoplasmic reticulum lumen, which is suggestive of non-classical secretion. This export pathway 
is generally known as ‘leaderless protein secretion’ (Nickel 2003; Bendtsen et al. 2004) and was 
described recently also in P. falciparum (Lingelbach and Przyborski 2006; Sudarsan et al. 2015; 
Thavayogarajah et al. 2015). We screened the B. canis exportome for additional motifs associated with 
protein trafficking into the host cell and beyond. We searched specifically for matches to Plasmodium 
host targeting (HT) motifs or PEXEL export elements (RxLxE/Q/D) for trafficking beyond the 
parasitophorous vacuolar membrane (PVM) (Hiller et al. 2004; Marti et al. 2004), which have been also 
identified in T. gondii and C. parvum (Hsiao et al. 2013; Pelle et al. 2015). Although Babesia builds a 
PVM during invasion of RBC it disappears within minutes and the parasite resides directly in the host 
cell cytoplasm (Asada et al. 2012). A comprehensive comparative in silico analysis of protein export 
across 10 Apicomplexa species revealed PEXEL-like motifs (PLM) in B. bovis (but not in T. parva) with a 
role in retention of these proteins in so called spherical bodies and release in a cell-cycle dependent 
manner (Pelle et al. 2015). We found hits for the B. bovis PEXEL-like motifs within the first 100 N-
terminal amino acids in 64.3% of cSP-containing proteins and only in 7.6% of predicted alternatively 
secreted B. canis proteins (Supplemental Data S3). Using a hidden Markov model to identify alternative 
motifs by de novo pattern discovery did not yield any additional hits. 
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Shotgun proteomics and transcriptomics identify potential B. canis-specific secreted virulence factors 
during severe disease 
Proteins involved in parasite-host interactions at acute crisis were identified by a comparative shotgun 
approach from B. canis BcH-CHIPZ infected and healthy host blood samples. Mass spectrometry 
datasets were generated from secreted soluble factors collected from pooled short-term cultures from 
three experimentally infected dogs at acute crisis and RBC cultures derived from healthy blood donors, 
as well as from RBC membrane fractions from experimentally infected animals and non-infected 
controls. Using stringent thresholds to include only MS spectra with high peptide counts and after 
filtering the data with the non-infected control sets we identified a set of abundant parasite-specific 
proteins in these fractions. Based on their abundance in the iRBC and/or culture supernatant the 
identified secreted membrane-bound and soluble parasite proteins were considered candidate factors 
involved in host-pathogen interaction (Table 2; Supplemental Fig. S2). 
Not surprisingly, considering the limited understanding of apicomplexan pathogenicity determinants, 
the resulting B. canis dataset of abundant exported proteins comprises 47.8% (11/23) hypothetical 
proteins. The annotated proteins were parsed as follows: Factors on cell surface membranes (from the 
parasite or the iRBC) which include 2 variant erythrocyte surface antigens (VESA) located on the surface 
of iRBC, a Babesia spp. membrane protein (homologous to B. bovis, B. microti, B. bigemina, Theileria 
annulata, T. equi, T. orientalis, T. parva, and Cytauxzoon felis), a spectrin repeat superfamily 
extracellular matrix binding protein with homology to B. bovis VESA, and 2 merozoite surface antigens 
of the Bc28 gene family. These proteins where shown to be involved in survival and virulence of several 
hemoprotozoa species (Foley et al. 1994; Brayton et al. 2007; Gohil et al. 2010; Lau et al. 2011; Yang 
et al. 2012; Carcy et al. 2015). The dataset comprises SA1 and SA3, belonging to the above described 
third-largest exported family of proteins (secreted antigen family) suggesting a role in host-parasite 
interaction. The B. canis dataset also contains profilin, a secreted virulence factor described in P. 
falciparum and T. gondii with important roles in the process of crossing biological barriers during host 
cell invasion and egress (Kursula et al. 2008; Plattner et al. 2008), a SET-domain containing protein with 
putative function in lateral gene transfer in apicomplexans (Kishore et al. 2013), and a SNARE protein 
mediating membrane fusion of secretory vesicles with the plasma membrane (Ayong et al. 2007; Parish 
and Rayner 2009). Furthermore, a secreted histone protein (classified as DNA-binding protein) was 
detected. Histone proteins were described to have moonlighting functions outside of the nucleus in P. 
falciparum, specifically at the interface between parasite and erythrocyte cytoplasm, i.e. the 
parasitophorous membrane (Luah et al. 2010). 
All hits in the proteomic dataset for which GO descriptions or blast homologies could be assigned were 
further validated using transcriptome evidence (threshold FPKM value > 10). Only Bc28.2, a known 
secreted B. canis-specific protein (Yang et al. 2012), fell below this threshold with a measured FPKM 
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of (4.5). However, the correlation between transcript- and protein abundance is not linear and there 
is a complex relationship leading to notable discrepancies due to a range of factors such as protein- 
and mRNA turnover (Wastling et al. 2012). Taken together with additional evidence from the literature, 
these proteins are good candidates for factors that are presented to the host on the parasite or iRBC 
surface, or released in to the bloodstream and potentially involved in parasite persistence and 
virulence. 
 
Correlating parasite gene expression and disease parameters of B. canis babesiosis at acute crisis 
We collected biological material from three experimentally infected dogs, which all showed very 
similar rapid disease progression consistent with fatal babesiosis (described in Eichenberger et al. 
2016). The first mild clinical signs (e.g. lethargy) preceded acute crisis with early symptoms of septic 
shock by a maximum of 27 hours (Supplemental Fig. S3). In spite of the fulminant disease 
manifestation, a hallmark of canine babesiosis is a remarkably low-grade parasitemia (Schetters et al. 
1997; Furlanello et al. 2005; Schetters et al. 2009) typically with <2% infected erythrocytes observed 
in the peripheral blood. The erythrocytic stages of the parasite are entirely responsible for the 
morbidity and mortality associated with canine babesiosis. Morphological characterization of blood 
stage parasites revealed pleiomorphic forms in Giemsa-stained blood smears derived from a critically 
ill dog (Fig. 4A). Small and large ring stages were the most frequently detected forms, while only few 
classically pear-shaped forms could be identified. To characterize the parasite stages in iRBC from 
experimentally infected animals on a molecular level in more detail, we used the high-throughput RNA-
seq data to identify orthologous gene models with stage-specific expression in Plasmodium spp. We 
intersected the list of B. canis gene models with evidence for expression with a list of validated 
Plasmodium spp. stage-specifically expressed genes (e-value threshold of 10E-3) (Supplemental Data 
S4). We found evidence for RNA-seq reads (threshold FPKM>10) mapping to 22 of 29 conserved 
merozoite-, and 4 of 7 early gametocyte genes in a blood sample collected from a splenectomized dog 
(Fig. 4B). The higher abundance of merozoite- (proliferative) and early gametocyte-specific 
orthologues (sexual stage) during severe disease was consistent with the microscopy data and 
suggested a paucity of circulating sexual stages in this sample. Nevertheless, some evidence for early 
gametocyte stages was found, which could indicate that acute clinical crisis in infected dogs might 
trigger development of sexual stages. For example in Plasmodium, gametocyte formation occurs in 
bone marrow and aggravates clinical symptoms and disease outcome (Aguilar et al. 2014; Joice et al. 
2014). A potential bone marrow tropism could explain typical clinical signs, e.g. leucopenia and 
thrombocytopenia, associated with poor outcome in acute B. canis infections (Eichenberger et al. 
2016). B. canis orthologues of the 18 identified invertebrate stage-specific proteins (flagellar “late” 
gametocyte-, ookinete- and sporozoite genes) described for Plasmodium had FPKM values between 0 
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and 10.8, indicating that no or only insignificant amounts of these mRNAs were detected in the 
sampled parasite population. Based on the degree of orthologue conservation and the microscopy 
data we interpret this as paucity of late gametocyte stages in the peripheral blood (Supplemental Data 
S4). 
Comparative analysis of the B. canis secreted- and RBC-associated proteomes revealed members of 
the Bc28 and SA protein family. The annotation for the B. canis BcH-CHIPZ genome contains 24 gene 
models coding for members of the SA- protein family. By aligning the SA-family members using Clustal 
Ω, shared amino acid motifs at the N-terminal part of the predicted proteins were revealed 
(Supplemental Fig. S4). Some SA genes have been identified in other Babesia species (Jia et al. 2006; 
Jia et al. 2009; Luo et al. 2011; Sevinc et al. 2015). However, this gene family appears to be expanded 
in Babesia species infecting canines: cluster analysis with B. bovis, B. bigemina, and rodent B. microti 
genome data did not identify shared clusters, whereas pBLAST searches showed high homology to two 
known B. gibsoni secreted antigens (SA-1 and SA-3; Supplemental Data S5). 
Currently, two members of the Bc28 gene family are characterized as major merozoite surface antigens 
playing a critical function in the interaction of merozoites with RBC (Carcy et al. 2006; Yang et al. 2012). 
The 20 B. canis family members (including the two characterized Bc28 proteins) which clustered in 
OrthoMCL were aligned using Clustal Ω (Supplemental Fig. S4 B). Our data support the previous 
classification of Bc28.1 (Yang et al. 2012) as a GPI anchored membrane protein. Other Bc28.1 family 
members lack both GPI-anchor signal and transmembrane domain, but are still are predicted to be 
exported by virtue of a canonical hydrophobic signal peptide or an alternative route (Fig. 3). 
Discussion 
Secreted soluble and membrane-targeted parasite proteins have important roles at the host-parasite 
interface and are frequently virulence and pathogenesis factors. Systematic investigation of these 
interactions in infections with potentially fatal blood-borne parasites, such as the difficult to cultivate 
Babesia canis, which modify the host cell, its microenvironment, as well as host physiology in multiple 
ways, is a challenge. Moreover, these questions cannot be addressed with biological material from 
regular patients from an animal clinic. Hence, in this study, we used experimental infections of dogs in 
a controlled setting to gather data on disease progression, clinical parameters, and parasite 
development. We report first genome and gene expression data of the apicomplexan B. canis with a 
focus on exported factors secreted during acute infection. Acute B. canis infections with fulminant 
disease progression is associated with high mortality and characterized by an excessive inflammatory 
response caused by protozoal sepsis. This is caused by dysregulation of pro- and anti-inflammatory 
mechanisms during the acute phase of the disease, resulting in shock and end-organ failure 
(Udomsangpetch et al. 1997; Clark et al. 2006; Matijatko et al. 2012). Interestingly, fatal B. canis 
infections (natural and experimentally induced) are invariably associated with at most moderate non-
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hemolytic anemia and very low parasitemia (Schetters et al. 1997; Furlanello et al. 2005; Eichenberger 
et al. 2016). This strongly suggests that potent secreted parasite factors are responsible for the severe 
pathogenicity of canine babesiosis. Hence, these as yet uncharacterized, secreted virulence factors are 
prime targets for inclusion into vaccines but also in the development of diagnostic kits. A particular 
challenge in treating canine babesiosis is the combination of unspecific symptoms, late presentation, 
and rapid progression of the disease to a life-threatening stage. Thus, tools for early and accurate 
diagnosis of canine babesiosis as a prerequisite for initiating specific treatment and prevent fatal 
outcome are missing and are therefore a prime goal in clinical research. Secreted soluble antigens in 
acute B. canis infections circulate in the bloodstream from the onset of parasitemia and before specific 
antibodies are present, as seroconversion usually takes at least 8 to 10 days (Sibinovic et al. 1967; 
Bobade et al. 1989; Vercammen et al. 1995; Schetters et al. 1996). Given the generally very low 
parasitemia and difficult to identify pleiomorphic stages, these circulating Babesia antigens are prime 
targets for early and rapid diagnosis in acute infections. This principle was implemented recently in a 
species-specific rapid diagnostic test for acute malaria by detection of several secreted soluble 
histidine rich parasite proteins (HRP2) with monoclonal antibodies (Merwyn et al. 2011). 
As a prerequisite for the study of parasite factors interacting with the host we report an annotated B. 
canis reference genome. Based on a next-generation high throughput approach (PacBio SMRT-
sequencing) we generated 43 high-quality contigs at 55-fold average coverage with a total length of 
approximately 7 Mb. The quality of the genome annotation is key for subsequent gene expression 
analysis by RNA-seq or MS analysis of peptides. Annotation of BcH-CHIPZ genome was based on a 
combination of ab initio gene predictions trained on high-quality annotated P. falciparum, B. bovis, 
and Theileria annulata genomes, and combined with de novo transcriptome data (assembled Illumina 
RNA-seq reads) from B. canis blood stages resulting in 3467 gene models. By mapping gene-clusters 
shared among hemozoa species we were able to assign all B. canis contigs to 4 B. bovis chromosomes. 
This suggests that the nuclear B. canis genome is likely organised on 4 chromosomes, similar to the 
genomes of the phylogenetically related B. bovis (Brayton et al. 2007), B. bigemina (Jackson et al. 
2014), and B. microti (Cornillot et al. 2013). We found that 92.6% of the B. canis gene models are 
designated as core eukaryotic genes, which also map to the Toxoplasma gondii genome dataset (Parra 
et al. 2009), and 94.8% (1722/1822) of orthologous clusters can be identified in one or more annotated 
Babesia species. Taken together, we considered the BcH-CHIPZ genome assembly and annotation as 
sufficiently robust for transcriptomic and proteomic analyses of secreted effectors. Considering that, 
similar to human malaria (Miller et al. 1994), the clinical presentation of canine babesiosis is caused by 
blood stage parasites alone, understanding the clinical manifestations of the disease requires 
identification and characterization of parasite antigens that interact with the host beyond the iRBC. To 
address this question we generated a high-quality blood-stage transcriptomic dataset (118 million 
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mapped reads on the B. canis genome) and a proteomic dataset representing a secreted- and 
membrane-associated protein fraction from a blood sample collected at the onset of acute crisis in 
experimentally infected dogs. 
Several major secreted factors for acute pathogenicity and persistence of hemoprotozoan parasites, 
have been described in P. falciparum and B. bovis (Allred and Al-Khedery 2004). Following RBC 
invasion, B. bovis exports VESA proteins to the surface of the host cell modifying the iRBC membrane 
to induce cytoadherence of iRBC at the capillary and postcapillary venous endothelium (Allred et al. 
1994; O'Connor et al. 1997; Allred et al. 2000). VESA expression is subject to rapid antigenic variation 
defined as the serial clonal replacement of the expressed VESA gene in daughter merozoites before 
invasion of a new RBC. This gives rise to antigenically distinct parasite populations, which complicates 
mounting of an effective host immunity. Antigenic variation, i.e. sequential exposure of different sets 
of surface antigens is likely a universal immune-evasion strategy among hematozoa and has been 
documented in several Babesia and Plasmodium species including B. rodhaini, B. microti, B. bigemina, 
P. falciparum and P. vivax (Allred and Al-Khedery 2006; Singh et al. 2014). Not surprisingly, the largest 
exported protein family in B. canis consists of the variant erythrocyte surface antigen (VESA) proteins. 
Indeed, a recent study using comparative transcriptomics and proteomics of attenuated and virulent 
B. bovis strains showed a significantly increased diversity of upregulated VESA genes in virulent strains 
(Pedroni et al. 2013). In the present study, we detected a high number (74/103) of transcribed VESA 
genes as well as their products in the B. canis secreted proteome. Hence, adherence of B. canis iRBC 
to endothelial cells is one explanation for the apparent discrepancy between the low parasitemia 
observed in peripheral blood samples and the severity of the disease, consistent with sequestration of 
parasites and removal from the peripheral circulation. Correspondingly, using parasites isolated from 
a peripheral blood sample for the transcriptomic and proteomic studies might introduce a bias with 
respect to the detection of important pathogenicity factors. Interestingly, only 6 of the 103 VESA gene 
models in B. canis are predicted to encode a classical N-terminal signal peptide, in line with data from 
B. bovis (7 out of 119) (Brayton et al. 2007), suggesting an alternative route for export of most of the 
members of this protein family. 
Shedding of extracellular (exosome-like) vesicles (EVs) as membrane-bounded carriers for proteins, 
lipids and RNA for intra- and inter-species communication (reviewed in (Raposo and Stoorvogel 2013; 
Yanez-Mo et al. 2015) was identified recently as a non-classical export pathway for a completely new 
class of important parasite-derived factors. In P. falciparum infections the concentration of EVs in the 
blood is positively correlated with severe disease suggesting an important role in pathogenesis and 
immune modulation (Nantakomol et al. 2011). Strikingly, the B. canis BcH-CHIPZ genome encodes 
homologues of important structural proteins and enzymes frequently found in exosomes, including 
heat shock proteins (e.g. HSP70 and 90), tetraspanins and ALIX protein, TSG101/ESCRT protein, 14-3-
PART III     MANUSCRIPTS 
- 45 - 
3 protein, thioredoxin peroxidase, histones, and the RAB GTPases 5, 7, 11, as well as a RAB GDI (Thery 
et al. 2002; Silverman and Reiner 2011; Raposo and Stoorvogel 2013). Based on their biogenesis, 
exosomes often contain endosome-associated proteins, such as a B. canis SNARE protein detected in 
the culture supernatant. In P. falciparum a SNARE protein was localized proximal to the plasma 
membrane where it is possibly involved in membrane trafficking events associated with the parasite’s 
food vacuole (Parish and Rayner 2009). Hence, EVs in B. canis infections could be crucial vehicle carriers 
for the dissemination of pathogenicity factors that are linked to acute and severe disease, including 
coding and non-coding RNA which can interfere with host cell gene expression. In fact, secretion via 
EVs could account for many of the non-classically secreted proteins detected in the B. canis proteomic 
datasets. We identified several proteins with moonlighting functions which have been identified as 
virulence factors in related Apicomplexa. For example profilin (pfn) was shown to have important roles 
in the process of crossing biological barriers during host cell invasion and egress, in addition to its 
classical role as a regulator of actin dynamics (Plattner et al. 2008). The structure of the P. falciparum 
pfn accommodates additional domains with as yet unknown functions, which are potentially involved 
in the parasite-host interplay (Kursula et al. 2008). Another interesting finding was a histone protein in 
the iRBC membrane fraction. Histones are classically localized in the cell nucleus with functions in 
chromatin remodeling and transcriptional regulation. In several Plasmodium species, a histone protein 
methylated at position L9 was detected in the PV membrane (Luah et al. 2010). The conserved PVM 
localization in Plasmodium indicated that histones have evolved additional functions as virulence 
factor in invasion and/or interaction with the host. As Babesia are not contained within a PV, the 
potential moonlighting function of this protein will have to be further investigated. Furthermore, 
histones are commonly found in large EVs (Colombo et al. 2014). We also detected a B. canis SET-
domain containing protein (BcSET) in the secreted soluble fraction. SET proteins are involved in diverse 
mechanisms such as transcriptional regulation, enhancer function, mRNA splicing, DNA replication, 
and DNA damage response (Herz et al. 2013). An exported SET exerting an immune-suppressive 
function by transcriptional silencing of host gene expression was described in the pathogen Bacillus 
anthraxis (Mujtaba et al. 2013). Interestingly, deregulation of gene expression due to SET domain-
containing proteins is correlated with unfavorable clinical outcomes in various forms of cancer (Greer 
and Shi 2012). 
Members of the Bc28 and SA gene families are among the most prominent B. canis-specific secreted 
factors, and have recently gained attention as candidates for innovative vaccine strategies and in 
diagnostics (Yang et al. 2012; Zhou et al. 2016). Bc28 gene products are highly represented on the 
merozoite surface, but are also shed and can interact with the iRBC membrane (Yang et al. 2012). Bc28 
belong to a multigene family composed of polymorphic genes. Different B. canis strains in Europe are 
associated with different mortality rates and show genetic heterogeneity in Bc28.1, detectable by a 
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PCR-RFLP test (Carcy et al. 2015). It has been suggested that this variable repertoire has evolved to 
allow the parasite to evade host immune responses, although merozoite surface proteins of Babesia 
spp. are thought to be the main targets of the adaptive host immune response (Carcy et al. 2006; Goo 
et al. 2012). However, whether all members are directly involved in immune evasion and virulence, or 
even show stage-specific behavior, will have to be investigated in more detail. 
In the absence of reverse genetic techniques for B. canis research the sequencing and annotation of a 
virulent B. canis strain together with the described parasite blood stage proteome and transcriptome 
provides a powerful underpinning for designing targeted intervention strategies such as the 
development of novel diagnostic tools, effective vaccines, and innovative drugs. 
 
Methods 
Parasites 
Biological material for the different experiments were collected from experimentally infected dogs. 
Animals were inoculated intravenously with 1 x 106 parasitized erythrocytes from a cryo-conserved 
field isolate, derived from a naturally infected Bernese mountain dog from Switzerland that had been 
exposed during a trip to Hungary. All experimentation with animals was in complete compliance with 
the strict Swiss animal welfare laws and regulations (Permit 122/2012), issued by the Veterinary Office 
of the Canton of Zurich, and round the clock surveillance by a veterinarian.  Whole blood was treated 
with citrate-phosphate-dextrose-adenine (12.3% CPDA-1, v/v) for anticoagulation under sterile 
conditions and prepared immediately after euthanasia. Blood samples for genomic and transcriptomic 
studies were collected from an experimentally inoculated splenectomized dog (4 years old). 
Splenectomy increased the final amount of parasites in the peripheral blood to approximately 4% 
infected erythrocytes. The biological material for the proteome analysis was collected from three 
experimentally infected adult beagles with a parasitemia of 1 – 1.75% (Supplemental Fig. S2). 
 
Genome sequencing, assembly, and annotation pipeline 
Genomic DNA (gDNA)was prepared from purified and host leukocyte-depleted (Sriprawat et al. 2009) 
infected blood from an experimentally infected, splenectomized dog. High-throughput genome 
sequencing was performed on a PaciBio Single Molecule Real Time (SMRT) sequencing platform (Eid 
et al. 2009) run on 4 SMRT cells. 5 μg of input gDNA was used for library construction. Sequenced 
fragments were filtered to eliminate Canis familiaris reads and processed for assembly with PacBio 
read-alignment software BLASR (Chaisson and Tesler 2012). The final draft of the genome was 
obtained using a two-step procedure. De novo assembly was initially performed using the HGAP2 
algorithm (Chin et al. 2013) and the outcome was further polished using the PacBio proprietary analysis 
package Quiver, a reference-guided consensus tool used as part of the SMRT analysis. The resulting 
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draft was subjected to gap-closing and further scaffolding using PBJelly v14.1.15 (English et al. 2012). 
Genome annotation was performed using different sources of evidence-based prediction on the 
Maker2 pipeline (Stanke and Waack 2003), on ab initio gene predictor algorithms (Korf 2004) with P. 
falciparum 3D7, B. bovis T2Bo, and T. annulata Ankara gene models as templates, and on Trinity-
assembled de novo transcriptome evidence (Haas et al. 2013). Repetitive genomic elements were 
identified and masked from annotation with RepeatMasker using the full Repbase database (Jurka et 
al. 2005). Redundant transcripts potentially representing sequencing errors or genetic polymorphisms 
were clustered with the cd-hit software (Fu et al. 2012). Non-overlapping sequences of the different 
evidence datasets were generated from the gff-files with BEDTools genome arithmetic software 
(Quinlan 2014). Functional annotation of the gene-predictions was achieved by gene ontology mapping 
through Blast2Go v3.1 (Conesa et al. 2005) using a upper cut-off e-value of < 0.0005.  
Full methodological details are provided in the Supplemental Material. 
 
Wet lab transcriptomics, and RNA seq data analysis 
Total RNA was prepared from host leukocyte-depleted B. canis blood stages using the Zymo Direct-zol 
RNA MiniPrep kit (Zymo Research) including an on-column DNase I (QIAGEN) digest. Paired-end, 
stranded sequencing of the cDNA library was performed on 1 lane of a Illumina HiSeq 2000 sequencer 
(Illumina Inc.). Measurement of expression level was based on fragments per kilobase of exon model 
per million mapped reads (FPKM), normalized by the length of the gene. A gene was considered 
expressed if its FPKM was at least 10. Full methodological details are provided in the Supplemental 
Material. 
 
Summary of computational genome analysis 
The identification of potential homologues of B. canis genes to selected apicomplexan parasites (B. 
bovis T2Bo, B. bigemina BOND, B. microti RI, T. annulata Ankara, P. falciparum 3D7, and T. gondii 
ME49) was carried out by protein blast (Blast+ executables v2.2.31) of each individual protein 
sequence. A e-value < 0.001 cut-off was considered appropriate. For comparative genomics analysis of 
species-specific genes and clustering of orthologues, OrthoMCL (v2.0.9) was used (Li et al. 2003; 
Fischer et al. 2011). Synteny analysis was performed in MCScanX (Wang et al. 2012) by the pairwise 
determination of syntenic regions between species based on the order of orthologues from the 
OrthoMLC output with default values. B. canis contigs were arranged according to the syntenic 
relationship to B. bovis with ‘orderchr’ execution in Circos utilities. Figure was drawn with Circos 
(Krzywinski et al. 2009). Prediction of the B. canis exportome was based on several in-silico analysis 
tools, databases, and manual curation (Supplemental Fig. S1). Full methodological details are provided 
in the Supplemental Material. 
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Proteomic studies 
Proteomic analyses were based on secreted soluble Babesia antigens and membrane-bound B. canis 
proteins. Culture supernatant was collected after 18 h of short term in-vitro parasite cultures of B. 
canis RBC in serum-free medium prepared from anticoagulated whole blood from experimentally 
inoculated dogs. Similarly, blood from a healthy canine blood donor was cultured and supernatant was 
processed as a control. Isolation of membrane bound proteins was based on anticoagulated, 
leucocyte-depleted blood. IRBC were concentrated by Percoll (GE Healthcare) gradient centrifugation 
(Figueroa et al. 1990) and parasites were released from the iRBC by streptolysin-O mediated lysis 
(Richier et al. 2006) and removed by an additional Percoll gradient centrifugation step (Rodriguez et 
al. 1986). Membrane proteins were collected by homogenization and repeated ultracentrifugation 
steps, mild sonication and acetone precipitation. The same protocol was used to collect proteins from 
uninfected erythrocyte membranes. All samples were collected and stored at -80°C until further use. 
Protein preparations were separated on one dimensional SDS-PAGE under sterile and reducing 
conditions. Each stained gel was cut into 8 equal sections and in-gel trypsin digested for subsequent 
mass spectrometry analysis. Liquid chromatography-MS/MS was performed on a Q-exactive mass 
spectrometer (Thermo Scientific) equipped with a nanoAcquity UPLC (Waters Corporation). 
Following peptide data acquisition, searches were performed using the MASCOT search program 
against a database build on the B. canis annotated genes with a concatenated decoy database 
supplemented with commonly observed contaminants and the Swissprot database to increase 
database size, or against NCBI database for Canis lupus familiaris. Identified hits were filtered in 
Scaffold Viewer V4 (Proteome Software, Portland, US) based on stringent parameters to reach false 
discovery rates of <5%. Furthermore, all datasets were corrected for obvious host- and environmental 
contaminants by an additional pBLAST search of the NCBI non-redundant protein sequences database 
with the single peptide hits. 
 
Data access 
Sequences and data were deposited for public access on the ProteomeXchange platform via PRIDE 
(http://www.proteomexchange.org). The annotated B. canis genome is being made accessible through 
PiroplasmaDB (http://piroplasmadb.org/piro/). 
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Tables 
Table 1. Genome characteristics of related apicomplexan hemoprotozoa 
 Species 
Features B. canis 
[CHIPZ] 
B. bovis 
[T2Bo] 
B. microti 
[RI] 
Th. annulata 
[Ankara] 
P. falciparum 
[3D7] 
Genome size (Mb) 7 8.2 6.5 8.4 23.3 
# of chromosomes 4 4 4 4 14 
# of scaffolds 43     
G+C content (%) 45.8 41.5 36 32.5 19.4 
Protein coding genes 3467 3706 3513 4082 5383 
Mean gene length (bp)1 1044 1503 1327 1602 2292 
% of coding regions 51.7 68 73 73 53 
Gene density2 2020 2194 1816 2199 4374 
1excluding introns and UTRs 
2Genome size/number of protein coding genes 
 
Table 2. List of B. canis specific candidates from culture supernatant derived and membrane-bound protein fractions. 
Identificatio
n 
GO-description1 SP TM GPI AS Apicomplexan 
orthologue2 
Transcriptome 
evidence 
(FPKM) 
Specific B. canis secreted soluble proteins: 
BcH000240 hypothetical 
protein, conserved 
1 6 0 0  no (0.7) 
BcH000493 N/A [VESA] 0 0 0 1 VESA 
(B. bovis BBOVII004140) 
yes (673.5) 
BcH001113 hypothetical 
protein, conserved 
0 0 0 0  yes (544) 
BcH002928 hypothetical 
protein, conserved 
1 0 0 0  yes (64.2) 
BcH003445 Secreted antigen 3 0 0 0 1 Secreted antigen 3 
(B. gibsoni BAH70325) 
yes (26.4) 
BcH000300 Merozoite surface 
protein (Bc 28.2) 
1 0 0 0 B. canis specific no (4.5) 
BcH002050 SET domain-
containing protein 
0 0 0 0 SET- and MYND domain 
containing protein, 
putative (B. bigemina 
BBBOND0302680) 
yes (147.6) 
BcH002986 hypothetical 
protein 
0 0 0 0  yes (60.1) 
BcH003048 Profilin 0 0 0 0 Polypeptide of profilin 
(B. bigemina 
BBBOND_0104160) 
yes (100.6) 
BcH002141 Snare protein 0 1 0 0 Snare protein, putative 
(B. bigemina 
BBOND0107960) 
yes (236.6) 
BcH000974 hypothetical 
protein, conserved 
1 0 0 0 VESA 
(B. bovis BBOV_III006920) 
no (4.1) 
BcH000821 spectrin repeat 
superfamily 
0 1 0 0 VESA 
(B. bovis BBOV_II004140) 
yes (123.2) 
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extracellular 
matrix binding 
BcH000175 hypothetical 
protein, conserved 
0 0 0 0  yes (57.9) 
BcH002958 N/A [membrane 
protein] 
0 0 0 1 membrane protein, 
putative 
(B. bigemina 
BBBOND_0105580) 
yes (56.4) 
        
Specific B. canis host-RBC membrane presented proteins: 
BcH000821 Spectrin repeat 
superfamily 
extracellular 
matrix binding 
0 1 0 0 VESA 
(B. bovis BBOV_II004140) 
yes (123.2) 
BcH000300 Merozoite surface 
protein (Bc 28.2) 
1 0 0 0 B. canis specific no (4.5) 
BcH000299 Merozoite surface 
protein (Bc 28.1) 
1 1 1 0 B. canis specific yes (18.3) 
BcH002699 Histone h2a 0 0 0 0 41-2-protein antigen 
precurson, putative 
(B. bigemina 
BBBOND_0103700) 
yes (31.9) 
BcH001932 hypothetical 
protein, conserved 
0 0 0 0  (yes 12.5) 
BcH002268 hypothetical 
protein, conserved 
0 0 0 0  yes (111.9) 
BcH001655 VESA 0 0 0 1 VESA 
(B. bovis BBOV_IV002850) 
yes (884.1) 
BcH001448 hypothetical 
protein, conserved 
0 0 0 0  no (0.9) 
BcH003376 Secreted antigen 1 0 1 1 1 Secreted antigen 1 
(B. gibsoni ALE14558) 
yes (142.5) 
BcH000391 hypothetical 
protein, conserved 
1 0 0 0  yes (331.2) 
BcH000895 hypothetical 
protein, conserved 
0 0 0 0  yes (26.4) 
GO: gene ontology; SP: signal peptide; TM: transmembrane domain; GPI: AS: alternative secretion: GPI: 
glycophosphatidylinositol: VESA: variant erythrocyte surface antigen 
1 automated annotation by Blast2GO; [if no Blast2GO annotation could be assigned, best pBlast hit was provided in 
brackets] 
2 other than hypothetical 
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Figures 
 
Figure 1. Whole genome synteny of Babesia canis, B. bovis, and B. microti. Assembled B. canis contigs (top arc) were 
arranged based on synteny to related Babesia species. Predicted arrangement of B. canis contigs on four chromosomes is 
indicated by colours of the lines linking conserved genes. Blood stage mRNA expression data for B. canis genes is included 
(line plot); gene density is colour coded and represented as number of genes per 10kb (heatmap). Chromosomal distribution 
of B. canis VESA gene models is indicated with red dots. 
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Figure 2. Comparative analyses of the Babesia canis genome. Gene clusters among different apicomplexan parasites as 
identified by OrthoMCL. (A) Comparison of orthologous clusters in four Babesia species and (B) B. canis and representative 
Apicomplexa species. The number of orthologous groups is indicated in the intersections. The total number of gene-models 
and clusters for each species is shown in brackets. Orthologous gene clusters in (A) are divided into three categories (piechart 
colour code:  multigene family;  genes with annotations;  hypothetical genes). 
 
 
 
Figure 3. Conserved apicomplexa-specific exported protein families in Babesia canis. Individually identified gene models 
were assigned to gene families of phylum-specific exported proteins; bar colours in the graph indicate the predicted route of 
secretion and/or type of membrane anchoring. CSP: canonical signal peptide; aSP: alternative (non-classical) secretory 
pathway; TM: transmembrane domain; GPI: predicted glycophosphatidylinositol anchor. 
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Figure 4. Transcript abundance of exported Babesia canis proteins. Collated (A) and individually ordered (B-F) RNAseq data 
plots of members of 12 gene families, showing FPKM values for 103 gene models from the VESA- (B), 26 gene models from 
DnaJ- (C), 24 gene models from the SA- (D), 23 gene model for the PK- (E), and 20 gene models from the Bc28-multigene 
family. FPKM: Fragments Per Kilobase of exon model per Million mapped reads. 
 
 
Figure 5. Babesia canis blood stages. (A) Representative Giemsa-stained blood smears from an experimentally 
infected dog with severe shock-like clinical signs showing typical pleiomorphic morphological appearance of B. 
canis parasites (Parasitaemia of 1.5% infected erythrocytes). (B) Transcriptome analysis of B. canis homologs of 
validated Plasmodium spp. stage-specific genes in a blood sample collected from an experimentally infected 
splenectomized dog with clinical signs consistent with acute canine babesiosis. 
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Supporting information 
 
Supporting Information will be made available with the final version of the publication: 
Supplemental Data S1. OrthoMCL cluster list. Gene-clusters which are shared between 4 annotated 
Babesia species (B. canis, B. bovis, B. bigemina, B. microti) and gene-clusters which are shared between 
5 annotated Apicomplexa species (B. canis, B. bovis, Plasmodium falciparum, Toxoplasma gondii, 
Theileria annulata). 
Supplemental Data S2. OrthoMCL cluster list. Gene-clusters which are specific for assembled Babesia 
species (B. bovis, B. bigemina, B. microti) other than B. canis. (These gene-clusters are not present in 
the B. canis annotation). 
Supplemental Data S3. Predicted exportome of Babesia canis CHIPZ strain (Hungary) based on in silico 
analysis. 
Supplemental Data S4. Transcriptome analysis of stage specific genes in the B. canis genome. 
Annotated genes were blasted against a list of known and approved Plasmodium spp. stage-specific 
genes and FPKM values from the B. canis RNA-seq were assigned. 
Supplemental Data S5. OrthoMCL cluster list. Gene-clusters which are specific for Babesia canis as 
compared to other assembled Babesia species (B. bovis, B. bigemina, B. microti). 
Supplemental document S1. CEGMA completeness and completeness relative to Toxoplasma gondii 
core eukaryotic gene families in selected apicomplexan species. 
Supplemental document S2. Genome overview. 
Supplemental methods. Isolation of genomic DNA, library preparation and genome sequencing; 
Genome assembly and annotation; Analysis of genome completeness; RNA preparation, wet lab 
transcriptomics, and transcriptomic data analysis; Functional annotation and characterization; 
Prediction of exported gene models; Samples for proteomic studies; Mass Spectrometry and protein 
identification; References 
Supplemental Figure S1. Selection criteria for the identification of the Babesia canis exportome. 
Supplemental Figure S2. Venn diagram of specific B. canis exported proteins. 
Supplemental Figure S3. Parasitaemia, prognostic markers, and acute phase response in three dogs 
experimentally infected with B. canis. 
Supplemental Figure S4. Sequence similarities of highly B. canis specific gene families. Screenshots 
from ClustalΩ alignments of proteins which clustered in OrthoMCL analysis. 
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2.2. Prognostic markers in acute Babesia canis Infections 
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Abstract 
Background: Canine babesiosis, caused by Babesia canis, is a prevalent and clinically relevant disease 
in Europe. Severe acute babesiosis is characterized by a high mortality but prognosis is not always 
correlated with clinical signs, nor with the level of parasitemia. 
Objective: This study evaluated prognostic markers associated with poor outcomes in acute Babesia 
canis infections. 
Animals and Methods: We compared the results of routine laboratory profiles, hand-held lactate and 
glucose analyzer, and the acute phase response in 2 groups of naturally-infected dogs (7 survivors and 
8 non-survivors). Samples were collected at the time of first admission and before any treatment. 
Subsequently, the course of prognostic markers was followed in 3 dogs experimentally inoculated with 
B. canis. 
Results: Non-survivors showed significantly higher concentrations of lactate, triglycerides and 
phosphate and lower hematocrit, leukocyte counts, total serum protein concentrations, and 
thrombocyte counts when compared to survivors. All non-survivors (8/8) had hyperlactatemia, 
whereas most survivors (6/7) had values within the reference range. All survivors had leucocyte counts 
within the reference range, unlike the non-survivors, which showed leukopenia. During the course of 
acute babesiosis, the variables serum lactate, triglyceride, and phosphate concentrations, and 
thrombocyte count did exceed a prognostic threshold only during acute crisis. 
Conclusions and clinical importance: Poor outcome in acute B. canis infection is indicated by changes 
in the laboratory profile. Intensive care should be considered for dogs presenting with moderate 
anemia, severe thrombocytopenia, mild to moderate leukopenia, hyperlactatemia, moderately 
increased serum phosphate, and triglyceride concentrations, and moderately decreased total serum 
protein concentrations. 
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Abbreviations: ALT: alanine aminotransferase; AP: alkaline phosphatase; APP: acute phase protein; 
AST: aspartate aminotransferase; AUC: area under the curve; BW: body weight; CRP: C-reactive 
protein; DIC: disseminated intravascular coagulopathy; EDTA: ethylenediaminetetraacetic acid; hpi: 
hours post infection; IFAT: immune fluorescence antibody test; IQR: interquartile range; MCH: mean 
corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; MCV: mean 
corpuscular volume; PCR: polymerase chain reaction; RBC: red blood cell; ROC: receiver operation 
characteristic; SAA: serum amyloid A; WBC: white blood cell 
 
Introduction 
Canine babesiosis is a tick-borne disease caused by apicomplexan hemoprotozoan parasites. The 3 
distinct large Babesia species, B. canis, B. vogeli and B. rossi, and the small B. gibsoni, B. conradae and 
B. annae have been characterized in dogs.1-3 Babesia canis is the predominant and clinically relevant 
canine Babesia species in Europe 4 and infection typically is characterized by lethargy, apathy and pale 
mucous membranes. The disorder can manifest as a mild or severe form. The clinical signs of the severe 
form are variable and often related to an excessive inflammatory response syndrome associated with 
multiple organ dysfunction, shock and high mortality.3,5 
Hematological abnormalities in natural and experimental B. canis infections include anemia, 
thrombocytopenia and inconsistent leukocyte abnormalities such as leukocytosis, leukopenia, 
neutrophilia, neutropenia, and eosinophilia. The most common abnormalities in the serum 
biochemical profile are increases in the activity of aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT), hyperbilirubinemia, hypoalbuminemia, and electrolyte and acid-base 
abnormalities.6-10 Babesiosis in dogs affects primary and secondary blood coagulation and can induce 
disseminated intravascular coagulopathy (DIC).11,12 Furthermore, a systemic inflammatory response 
syndrome has been described in acute B. canis infection characterized by an acute phase response.12-
14 
The clinical manifestations of acute babesiosis are not always proportional to the degree of anemia, 
and are not correlated with the level of parasitemia, which often remains below 1%.1,6,15 Hence, 
besides mechanical erythrocyte damage, other pathophysiological mechanisms have been proposed 
to contribute to hemolysis, such as toxic hemolytic factors and immune-mediated destruction of 
erythrocytes.16 Furthermore, disease severity cannot be readily explained as a consequence of 
hemolysis alone, which often is mild to moderate in acute infections.6 Severe complications of acute 
Babesia infections have been described such as hemolytic and septic shock, acute renal failure, 
multiple organ dysfunction syndrome, and other complications.17,18 
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The clinical outcome of a B. canis infection is influenced by many factors and the primary 
pathophysiological mechanisms of babesiosis in dogs remain unclear.19,20 In canine B. rossi infections, 
poor prognosis and mortality are associated with hyperlactatemia, hypoglycemia, clinically 
compromised circulation, high parasite load, increased serum cortisol concentrations, and signs of 
consumptive coagulopathy.21-25 Accordingly in B. canis infections, an excessive inflammatory response 
with increased concentrations of fibrinogen, C-reactive protein (CRP) and secreted intracellular 
adhesion molecule-1 (sICAM-1) from erythrocytes, and thrombocytopenia have been associated with 
poor outcome.19 Furthermore, an increase in lipid mediators has been shown to be associated with 
severe complications such as development of systemic inflammatory response syndrome and multiple 
organ dysfunction.5,26 
We aimed to evaluate routine laboratory and rapid in-clinic laboratory tests for their applicability as 
prognostic markers associated with poor outcome in acute B. canis infections in dogs. 
 
Material & Methods 
Animals 
Naturally-infected animals. The prognostic potential of different laboratory tests was evaluated in 15 
naturally-infected animals, of which 12 dogs were presented to the Clinic for Small Animal Internal 
Medicine at the Vetsuisse Faculty, University of Zurich, and 3 dogs to private veterinary practices in 
Switzerland in the years 2011 to 2013. Inclusion criteria were the presence of acute clinical signs 
consistent with canine babesiosis at admission and the identification of large Babesia species by 
microscopic evaluation of Giemsa-stained blood smears. In each dog, B. canis diagnosis was confirmed 
by PCR 27 and direct sequencing of the amplicons.a At time of admission, blood samples were collected, 
and all animals were treated with antibabesial therapy (a single dose of 3 to 6 mg/kg body weight [BW] 
imidocarb diproprionate IM or combined with 10 mg/kg BW doxycycline PO every 12 hours for at least 
10 days, and a second dose of imidocarb diproprionate after 14 days). Dogs were enrolled whenever 
inclusion criteria were met and adequate samples were available. The animals were categorized into 
2 groups according to clinical outcome, which was defined as survival (survivor, n=7 dogs) or death 
(non-survivor, n=8 dogs). Six of the non-survivors died spontaneously within 24 hours of admission and 
2 dogs had to be euthanatized within 48 hours because ofclinical deterioration within 48 hours. 
Survivors were considered to be cured based on the absence of parasites 14 days after first admission 
on evaluation of Giemsa-stained blood smears and PCR. 
Experimentally-infected animals. The course of laboratory test results was evaluated in experimentally-
infected animals. Three facility-housed adult beagles (of which 1 was 4 years and 2 were 6 years old) 
were inoculated IV with approximately 1 x 106 parasitized erythrocytes from an isolate stored in liquid 
nitrogen. The parasite isolate originated from a naturally-infected Bernese mountain dog from 
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Switzerland that had travelled to Hungary. The experiments were terminated at the very first signs of 
acute crisis (which was defined as weak pulse, shallow breathing, somnolence, and any clinical signs of 
acute shock or central nervous depression). Experiments with dogs were conducted according to Swiss 
animal rights and regulations standards and approved by the Cantonal Veterinary Office of Zurich 
(permission number 122/2012) before the study. 
 
Samples 
Venous blood samples from the naturally-infected dogs were collected into tubes with and without 
ethylenediaminetetraacetic acid (EDTA) at the time of first admission and before any treatment. Serum 
and EDTA-preserved blood samples were collected through an indwelling catheter from the 
experimentally-inoculated dogs at different times. Additionally, citrated plasma samples were 
collected from these dogs at the end of the experiments. 
 
Analysis of blood samples 
Parasitemia was expressed as the percentage of infected erythrocytes in Giemsa-stained blood smears 
by manually scanning at least 5000 erythrocytes. Exposure to Ehrlichia canis and Anaplasma 
phagocytophilum was tested by an immuno-fluorescence antibody test (IFAT).b,c Complete blood cell 
counts were performed using EDTA-anticoagulated blood in an automated analyzer.d Hematological 
analysis included total white blood cell (WBC), thrombocyte and red blood cell (RBC) counts and RBC 
indices. Serum biochemical profiles were performed using an automated analyzer.e Laboratory 
reference intervals are stated as 5% and 95% quantiles. Portable hand-held devices for rapid in-clinic 
testing were used to measure concentrations of lactatef and glucoseg immediately in freshly collected 
EDTA samples.28,29 Serum CRP concentration was determined using a canine-specific 
immunoturbidimetric assayh and serum amyloid A (SAA) concentration was measured using a latex 
agglutination turbimetric immunoassay on an automated analyzer.e,i In the citrated samples from the 
experimentally infected animals fibrinogen concentrations were measured using the Clauss method 
and a semi-automated coagulometer.k D-dimer concentrations were measured on an automated 
analyzer.e,l 
 
Statistical analysis 
Results of the 2 groups (survivor and non-survivor) of naturally-infected dogs were compared by the 
Mann-Whitney U test. The initially significant variables then were analyzed with receiver operator 
characteristic (ROC) curves for which the area under the curve (AUC) was calculated. The ROC analysis 
was used for determining a prognostic cut-off value for best differentiating between survivors and 
non-survivors with a maximal Youden’s index.30,31 If the cut-off value fell within the normal reference 
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range, it was set at the corresponding border of the reference. Statistical analyses were performed 
using a statistical software package.m A p-value < 0.05 was considered statistically significant. The 
hematological and serum biochemical profiles from the samples collected at private practices were 
excluded from the analysis because these variables were measured with other analytical instruments. 
Hence, for these variables 6 survivors and 6 non-survivors were included. For parasitemia, variables 
from hand-held devices, and the acute phase response, all of the naturally-infected dogs were included 
in the analysis (7 survivors and 8 non-survivors). Graphs were generated using Graph Pad.n 
 
Results 
At admission all of the naturally-infected dogs had diverse clinical signs consistent with canine 
babesiosis including lethargy (all 15 dogs), pale mucous membranes (all 15 dogs), pigmenturia (10 of 
15), icterus (6 of 15), pyrexia (5 of 15), anorexia (4 of 15), vomiting (4 of 15), “water hammer” pulse (4 
of 15), and epistaxis (3 of 15). Although Babesia infection was assumed and antibabesial treatment 
initiated shortly after admission, 8 of the 15 dogs died or had to be euthanatized within 2 days of 
admission. All of the dogs were positive for B. canis in Giemsa-stained blood smears and by PCR, and 
none of these dogs reacted serologically to E. canis or A. phagocytophilum on IFAT. Data on 
characteristics of the individual dogs (animal description, travel history, and clinical signs) are 
summarized in supplemental file 1. No statistical difference in age, sex, and clinical signs was identified 
between survivors and non-survivors. 
The parasitemia ranged between 0.5 and 3.1% (median, 1.2%; interquartile range [IQR], 0.83-1.63), 
but no statistical difference was identified in the level of parasitemia between the survivors and non-
survivors. Results of laboratory findings as well as comparison between outcome groups are 
summarized in Table 1. In both groups of dogs, mild to moderate normochromic normocytic non-
regenerative anemia, mild to severe hyperbilirubinemia, mild to moderate azotemia, mild to moderate 
hypoalbuminemia, mildly increased alkaline phosphatase (AP) activity, moderate to severe 
hyponatremia, moderate hypocalcaemia and a mild to moderate increase in CRP concentration were 
observed commonly. Non-survivors had significantly higher concentrations of lactate (p<0.001), 
triglycerides (p<0.01), and phosphate (p<0.05) and significantly lower hematocrit (p<0.05), WBC 
counts (p<0.01), total serum protein concentrations (p<0.05), and thrombocyte counts (p<0.05) than 
survivors. 
These 7 initially identified prognostic factors were further analyzed by ROC analysis (Table 2). Of all 
variables studied, lactate concentrations and WBC counts showed the best prognostic sensitivity and 
specificity (both 100%) to differentiate between survivors and non-survivors. Figure 1 illustrates the 
significant prognostic variables for dogs in the 2 outcome groups. All non-survivors (8 of 8) had 
moderate to severe hyperlactatemia (median, 8.35 mmol/L; IQR, 7.18-9.13) whereas most survivors (6 
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of 7) had concentrations within the reference range (median, 1.6 mmol/L; IQR, 1.05-2.3). The WBC 
counts for all of the survivors (6 of 6) were within the reference range (median, 6.85 x103/µL; IQR, 6.03-
8.2) unlike the group of non-survivors, which had mild to moderate leukopenia (6 of 6; median, 2.65 
x103/µL; IQR, 1.7-3.53). 
The course of the prognostic variable, parasitemia and the acute phase response was followed in the 
3 dogs experimentally inoculated with B. canis. The 3 infected dogs became lethargic and showed signs 
of hemolysis (pale mucous membranes and pigmenturia) 105, 120, and 119 hours post-inoculation (on 
days 4 to 5), respectively. They had a low grade parasitemia with a maximum of 1.75% of the 
erythrocytes infected at the end of the experiment, and during the course 2 of the 3 dogs had episodes 
of pyrexia (Fig. 2a). An acute phase response could be observed with a moderate increase in CRP 
concentration and a moderate decrease in serum albumin concentration (Fig. 2b), whereas SAA 
concentrations remained below the diagnostic limit (data not shown). Follow-up of prognostic markers 
is shown in Fig. 3. A decrease in the hematological variables leukocytes, thrombocytes, and hematocrit 
was found before the identification of parasites in stained blood smears, and resulted in moderate 
leukopenia, severe thrombocytopenia and decreased hematocrit. In general, mild to moderate anemia 
was observed. Changes in lactate, triglyceride, and phosphate concentrations corresponded to the first 
appearance of parasites, and they only exceeded the prognostic threshold at the first observation of 
acute crisis. In addition, thrombocytopenia was a common finding and platelet counts exceeded the 
prognostic threshold toward the end of the experiment. Total serum protein concentrations also 
decreased over time but passed the threshold only in two of the three dogs before first signs of an 
acute breakdown. At the end of the experiment the three dogs showed mildly increased levels of 
fibrinogen of 2.6 g/L, 3.8 g/L, and 3.2 g/L (reference range, 1.0 – 2.5 g/L), and D-dimer concentrations 
of 0.26 mg/L, 0.44 mg/L, and 0.92 mg/L (reference range, <0.4 mg/L), respectively. 
 
Discussion 
In this study, several variables were shown to be associated with poor outcome in acute Babesia canis 
infections. By including 2 rapid in-clinic tests, standard hematological and biochemical variables, and 
acute phase proteins, we found the variables lactate, WBC, triglycerides, phosphate, thrombocytes, 
total serum protein, and hematocrit to be significant prognostic markers. Thus, non-survivors at 
admission had more severe anemia, leukopenia and thrombocytopenia in addition to alterations in 
their serum biochemical profile results. 
Lactate concentrations were significantly lower in survivors and showed a clear difference from the 
non-survivors. This finding is similar to what is observed in dogs infected with Babesia rossi, the agent 
of severe canine babesiosis in South Africa, where serum lactate concentration is used for post-
treatment monitoring, 21 and high blood lactate concentrations correlate with poor outcome.32-34 
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Nevertheless, the pathogenesis of hyperlactatemia in dogs with acute babesiosis is not well 
established, and it might not be caused by hypoxia as a consequence of anemia, which remains mild 
to moderate in most B. canis infected animals.34 Hence, hypoxia in canine babesiosis may be the 
consequence of alterations in the macro- and micro-cirulation triggered by protozoal sepsis, 
hypotension, DIC, and systemic inflammatory response syndrome (SIRS), all of which are well known 
in B. canis infections 18,35. Indeed, increased lactate concentrations have prognostic value in SIRS 
caused by various conditions.36,37 
The second variable that clearly differentiate between the 2 studied groups was WBC count. Non-
survivors had mild to moderate leukopenia, in contrast to the survivors with WBC counts in the 
reference range. Although the WBC count was a significant marker for outcome in our study, 
leukopenia was reported in 60% of mild cases of acute canine babesiosis.17 Indeed, the WBC count fell 
below the prognostic cut-off before any clinical signs were observed in the experimentally-inoculated 
dogs. Severely affected dogs had mild to moderate neutropenia, with an overall degenerative 
tendency and lacking a left shift (see supplemental file 2). Furthermore, lymphopenia seems to be a 
hallmark of acute canine babesiosis.17,19 A markedly increased serum cortisol concentration was found 
in dogs with lethal B. rossi infections, indicating a potential immuno-suppressed state in these animals, 
which also is indicated by an unexpected mild to moderate regenerative response of lymphocytes in 
dogs that survived.24,38 Furthermore, studies in humans with acute malaria infections with Plasmodium 
falciparum and P. vivax, which are related to Babesia spp., identified mechanisms that could explain a 
depletion of lymphocytes from the peripheral blood by acute sequestration of the cells in the lymph 
nodes or other parts of the body or by immune cell exhaustion and abnormal cell death through 
parasite-induced apoptosis.39,40 Similarly, toxic parasitic factors have been shown to be involved in 
canine B. gibsoni infection.41 
Hemolytic anemia and thrombocytopenia are the most frequent abnormalities associated with a 
diagnosis of B. canis in naturally-infected dogs and thrombocytopenia usually is the most dramatic 
hematological abnormality in the course of babesiosis.12,42-44 Our data indicate that severe 
thrombocytopenia is associated with poor outcome by a prognostic cut-off of 27,500 thrombocytes 
per µL, although a sensitivity and specificity of 83.3% for each indicates limited prognostic value. 
Presumably, several factors are involved in the origin of thrombocytopenia in canine babesiosis 
including increased platelet activation and consumption by a SIRS (hypercoagulable state), increased 
platelet sequestration and aggregation, and a decreased platelet production.19,45,46 Comparable in B. 
rossi infections, poor outcome was associated with a consumptive coagulopathy, although even severe 
thrombocytopenia was not accompanied by apparent bleeding diathesis and hemorrhage.25,47,48 
Increased phosphate concentrations often are associated with metabolic acidosis characterized by 
tissue hypoxia and high blood lactate concentrations, although the underlying mechanisms have not 
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been completely explained.49 Hemorrhage, hypovolemia, and shock as cause or consequence of tissue 
hypo-perfusion could further explain changes in altered variables, including also azotemia and 
potential protein-losing nephropathy caused by hypoxic renal damage.35 Complications related to 
hemolytic anemia, coagulation disorders and hypotension, SIRS, and secondary impaired renal 
function likely account for the severe outcome of the infection.6,9,10,12 Furthermore, in other studies, 
acute respiratory distress syndrome, renal failure, immune-mediated hemolytic anemia, cerebral 
syndrome, and DIC were associated with increased mortality in acute B. canis infections.17,50 
Acute phase proteins were used as prognostic factors for different inflammatory processes, 51 and an 
acute phase response also was observed in acute B. canis infections.12-14,20 We measured the acute 
phase proteins CRP and SAA, because they are considered major APP in dogs 52 and are not significantly 
affected by hyperbilirubinemia, which is commonly present in acute babesiosis.51 We found an 
increase in CRP before parasite detection as previously observed,12 without any significant difference 
between the outcome groups. This finding is in accordance with findings in B. rossi infections in which 
no prognostic value for CRP concentrations was observed.53 Furthermore, the SAA concentrations did 
not increase significantly in naturally- and experimentally-infected animals. This finding is in contrast 
to other observations of increased SAA concentrations in dogs with babesiosis on the day of 
admission.14 As another indicator, serum albumin concentration could serve as a negative APP.51 With 
the onset of acute infection, we observed a moderate decrease in serum albumin concentration and 
it had no prognostic relevance. Although differences between survivors and non-survivors were absent 
for an acute phase response, APP (among other variables) could serve as important variables for 
monitoring response to therapy.14,54 
In the course of validating prognostic markers in 3 experimentally-inoculated dogs, we observed low 
grade parasitemia with a maximum of 1.75% of infected erythrocytes, which was comparable to the 
group of naturally-infected animals. Even in infections with serious clinical signs, low parasitemia is a 
common finding in B. canis infections.1,6,12 The course in the infected dogs highlights the prognostic 
value of lactate, triglycerides, and phosphate concentrations, and thrombocyte counts, because these 
factors only crossed the prognostic threshold in an acute crisis. Referring to the ROC analysis of these 
variables, only lactate showed optimal characteristics. Therefore, any prognosis based on individual 
variables should be interpreted with caution. 
Missing data about the course of disease before admission and the time point of infection in the 
naturally-infected dogs is a limitation of this study. Generally, practitioners inquire about the duration 
of illness and the appearance of the first clinical signs, and they can estimate the time of the infection 
in affected dogs. In this respect, the prognostic markers are helpful for guiding clinical decision making. 
To get an overall picture of individual cases, a systematic collection of clinical, laboratorial, and other 
individual factors must be emphasized. For example, in our cohort of infected dogs, circulatory 
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disturbances were detected in 4 relatively young dogs (7 month to approximately 3 years), of which 3 
dogs died (see supplemental file 1). Such clinical variables could affect outcome in the laboratory test 
results and the likely progression of a patient’s infection.55 In any case, outcome depends on a rapid 
diagnosis and early treatment.  
Mortality in the investigated group of dogs was higher as compared to an endemic area.5 This finding 
reflects a typical situation for non-endemic areas such as Switzerland, where dogs became infected 
from local Babesia outbreaks or have traveled to an endemic area. These dogs likely never have had 
contact with the parasite and therefore did not develop partial immunity.46,56 Nonetheless, findings on 
mortality rates should not be over interpreted, because of the small sample size. In our cohort, we 
included every possible case for which we could obtain comparable laboratory data. 
Unfortunately, we did not have precise data about infection rates in dogs in Switzerland. However, 
during the sampling period, 2 indigenous outbreaks were reported in 44 dogs, of which 10 died.57,58 
Most indigenous cases in our cohort originated from these areas (4 survivors and 1 non-survivor) 
whereas 1 dog originated from Geneva, a known endemic region in Switzerland.59 The remaining 9 
infected dogs had a positive travel history. Information about infection rate in dogs in Switzerland that 
have travelled is rare. For example, from 2011 to 2013, the diagnostic unit of the Institute of 
Parasitology in Zurich (which offers a travel screening panel) identified 2.1% of 804 samples as positive 
on blood smears for large Babesia species (F. Grimm, personal communication). This observation is in 
agreement with observed cases in dogs in Germany that have travelled, with 3.7% (19/508) of animals 
positive for large Babesia spp. in Giemsa-stained blood or buffy coat smears.60 Hence, to compensate 
for the small sample size, prognostic markers were cross-validated in the course of experimental 
babesiosis. 
Although a significant prognostic marker is not necessarily clinically relevant, the pathophysiological 
reason for death would be of interest. With this in mind, additional studies should include post-
mortem examination, and more prognostic factor studies should be conducted including other non-
routine variables. The current study focused on rapid in-practice tests (e.g. lactate and glucose 
determined by hand-held analyzers) and routine laboratory variables, and the associated findings 
summarize the prognostic value of these variables. Nevertheless, additional research is needed to 
evaluate what additional evaluation and intensive care is needed for dogs with a poor prognosis. In 
this context, several markers have been demonstrated as good variables for follow-up and post-
treatment monitoring after antibabesial therapy, such as APP, lactate, thrombocytes, and 
leukocytes.13,14,21,43,54 
 
PART III     MANUSCRIPTS 
- 73 - 
Ethical standards and conflict of interest statement 
Animal experiments were carried out at the experimental units of the Vetsuisse Faculty at the 
University of Zurich after approval by the Cantonal Veterinary Office of Zurich (permission number 
122/2012) according to Swiss animal rights and regulation standards. 
The authors declare no conflict of interest. 
 
Footnotes 
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d Sysmex XT-2000iV, Sysmex Corporation, Kobe, Japan 
e Cobas Integra 800, Roche Diagnostics, Rotkreuz, Switzerland 
f Lactate Pro, Axon Lab AG, Baden, Switzerland 
g Accu-Chek, Roche Diagnostics AG, Rotkreuz, Switzerland 
h Gentian cCRP; Gentian AS, Moss, Norway 
i LZ Test SAA; Eiken Chemical Co., Ltd., Tokyo, Japan 
k STart 4, Roche Diagnostics AG, Rotkreuz, Switzerland 
l Tina-quant D-Dimer Gen.2, Roche Diagnostics AG, Rotkreuz, Switzerland 
m IBM SPSS statistics, 20.0.0, IBM Corp. Armonk, NY, USA 
n Graph Pad Prism 4, Graph Pad Software, San Diego, USA 
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Tables 
 
Table 1. Median values of various variables (minimum – maximum value) in dogs with naturally acute Babesia canis infections: 
a comparison between survivors and non-survivors. 
Variable (unit) Reference range Survivors Non-survivors p-value 
Parasitemia (%)  1.2 (0.5 - 3.1) 1.25 (0.5 – 1.9) 1 
Fast in-clinic variables 
Lactate (mmol/L) < 2.5 1.6 (0.5 – 3.6) 8.35 (4.3 – 11.8) <0.001 
Glucose (mmol/L) 3.9 – 6.7 4.8 (4.3 – 7.6) 5.2 (3 – 11.9) 1 
Hematological variables 
Hematocrit (%) 42 – 55 30 (25 – 40) 25.5 (17 – 28) 0.041 
Hemoglobin (g/dL) 14.4 – 19.1 11.45 (9.2 – 14.2) 9.05 (7 – 18.2) 0.240 
RBC (x1066/µL) 6.1 – 8.1 4.52 (3.95 – 6.2) 3.95 (3.05 – 5.39) 0.240 
MCH (pg) 23 – 26 24.5 (22 – 29) 23 (22 – 24) 0.180 
MCHC (g/dL) 34 -36 35.5 (34 – 36) 35 (35- -39) 0.937 
MCV (fL) 64 – 73 67.5 (64 – 74) 65 (58 – 67) 0.093 
WBC (x103/µL) 4.7 – 11.3 6.85 (5.1 – 9.2) 2.65 (1.59 – 4.5) 0.002 
Thrombocytes (x103/µL) 130 – 394 45 (17 – 190) 14.5 (6 – 41) 0.026 
Reticulocytes (%)  0.31 (0 – 0.81) 0.53 (0.29 – 1.17) 0.132 
Biochemical variables 
Total bilirubin (µmol/L) < 3.5 21.25 (4.7 – 85.3) 54.7 (19.7 – 221.8) 0.240 
Urea (mmol/L) 3.8 – 9.4 12.65 (4.5 – 25.7) 30.45 (6.2 – 79.4) 0.065 
Creatinine (µmol/L) 50 – 119 88 (75 – 133) 84 (54 – 651) 1 
Total protein (g/L) 56 – 71 57 (40 – 64) 44 (34 – 50) 0.026 
Albumin (g/L) 29 – 37 26.5 (19 – 38) 24 (13 – 26) 0.240 
Cholesterol (mmol/L) 3.5 – 8.6 6.25 (4.9 – 7.7) 6.05 (2.7 – 9.3) 0.589 
Triglycerides (mmol/L) 0.4 – 1.5 0.85 (0.8 – 1.1) 1.95 (0.9 – 3.5) 0.009 
Alkaline phosphatase (U/L) 20 – 98 113.5 (74 – 184) 253.5 (61 – 358) 0.132 
ALT (U/L) 20 – 93 47.5 (26 – 72) 72.5 (30 – 96) 0.132 
Sodium (mmol/L) 152 – 159 144.5 (132 – 154) 142.5 (140-151) 0.485 
Potassium (mmol/L) 4.3 – 5.3 4.2 (3.6 – 4.5) 4.4 (3.6 – 5) 0.394 
Chloride (mmol/L) 113-124 113.5 (97 – 115) 109 (94 – 121) 0.485 
Calcium (mmol/L) 2.4 – 2.8 2.43 (2.11 – 2.52) 2.225 (2.1 – 2.55) 0.180 
Phosphate (mmol/L) 1.0 – 1.6 1.36 (1.05 – 1.68) 2.54 (1.39 – 3.08) 0.015 
Acute phase response 
canine CRP (mg/L) < 5 84.7 (3.3 – 169.8) 155.55 (22.5 – 232.8) 0.189 
SAA (mg/L) < 2.19 0 (0 – 2.5) 0 (0 – 1.1) 0.536 
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Table 2. Results of the ROC analysis with prognostic cut-off values of significantly altered variables and respective sensitivity, 
specificity, area under the curve (AUC) and standard error (SE) associated with the outcome in Babesia canis infected dogs. 
Parameter (unit) Prognostic 
cut-off value 
Sensitivity (%) Specificity (%) AUC SE 
Lactate (mmol/L) 3.95 100 100 1.00 0.00 
Hematocrit (%) 28.5 66.7 100 0.86 0.11 
WBC (x103/µL) 4.7a 100 100 1.00 0.00 
Thrombocytes (x103/µL) 27.5 83.3 83.3 0.89 0.10 
Total protein (g/L) 50.5 83.3 100 0.88 0.12 
Triglycerides (mmol/L) 1.5 83.3 100 0.94 0.07 
Phosphate (mmol/L) 1.72 83.3 100 0.92 0.09 
a set at the border of the reference range (calculated cut-off at 4.8x103/µL) 
 
Figures 
 
Fig. 1. Prognostic markers in acute Babesia canis infected dogs. Median, and interquartile range for significant prognostic 
markers (p<0.05) recorded at admission in naturally infected dogs that did or did not survive an acute B. canis infection. Dots 
correspond to the data from individual dogs; the shaded grey areas represent the reference intervals. WBC: white blood cells 
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Fig. 2. Course of selected variables in 3 experimentally-infected dogs. Dog 1: solid line; dog 2: broken line; dog 3: dotted line. 
a: Body temperature (left y-axis) and parasitemia (right y-axes; lines with dots). The shaded grey area represents the reference 
interval for the body temperature. b: CRP (left y-axis) as a marker for positive acute phase response and albumin (right y-axis; 
lines with dots) as a marker for negative acute phase response. The shaded grey area represents the reference interval for 
albumin. hpi: hours post infection, CRP: C-reactive protein 
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Fig. 3. Course of significant prognostic markers in 3 experimentally-infected dogs. Dog 1: solid line; dog 2: broken line; dog 3: 
dotted line. The shaded grey areas represent the reference intervals. The horizontal broken lines represent the corresponding 
prognostic cut-off. a: blood lactate, b: WBC, c: triglycerides, d: phosphate, e: thrombocyte count, f: total protein, g: 
hematocrit. hpi: hours post infection, WBC: white blood cells 
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Supporting information 
Additional Supporting Information may be found online with the publication in ‘Supporting 
Information’: 
Supplemental file 1. Characteristics of the individual dogs (animal description, travel history, and 
clinical signs). 
Supplemental file 2. Data on differential WBC count. Differential WBC count in the course of three 
experimentally inoculated dogs, and in dogs that did or did not survive a naturally acquired acute 
Babesia canis infection.  
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Abstract 
Changes in the endemic foci of tick populations and invasions of tick species to new areas have become 
evident in Europe, leading to changes in the epidemiology of tick-transmitted diseases. However, data 
about tick infestations of pet animals are limited. Following the recent identification of a new focus of 
canine babesiosis in northeastern Switzerland, we investigated the occurrence of tick vectors in this 
region by using a pet owner-based sampling strategy. All dog owners in a rural town were sent postal 
requests to send ticks from their dogs and cats over two consecutive years, beginning in April 2012. In 
total 3003 ticks were submitted for identification from 249 dogs (approximately 20% of the resident 
dog population) and from 117 cats. Ixodes ricinus was the most abundant species identified in 96.8% 
(n=2124) and 74.3% (n=601) of the individual samples submitted from dogs and cats, respectively. Two 
other tick species, I. hexagonus and Dermacentor reticulatus, were recorded on both host species, with 
host infestation prevalences below 2%. On cats (but not on dogs), as many as 24.0% (n=194) of the 
specimens were identified as a fourth tick species, I. trianguliceps. Overall, 93.5% of the ticks were 
adults (93.8% and 93.0% in dogs and cats), 4.4% nymphs (5.7% in dogs and 1% in cats) and 2% larvae 
(0.5% and 6.0% in dogs and cats), respectively. The highest infestation intensity was 49 I. ricinus ticks 
from an individual dog. However, 55.6% of the submissions from dogs and 24.8% from cats contained 
only one tick. This survey demonstrated that pet owners can contribute to a cost-effective tick 
surveillance and identified a new tick focus of D. reticulatus. The finding of I. trianguliceps exclusively 
on cats might be related to behavioural traits of the cats or to a more readily detection of these very 
small ticks during petting by their owners. 
Keywords: dog; cat; Ixodes ricinus; Ixodes trianguliceps; Ixodes hexagonus; Dermacentor reticulatus.  
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Introduction 
Hard ticks (Ixodidae), frequently found on dogs and cats, bear the vector competence for a broad 
spectrum of pathogens of medical and veterinary significance (ESCCAP, 2012; Gray et al., 2009; 
Hillyard, 1996). In recent years, there have been changes in the endemic foci of tick populations, and 
invasions of tick species in central and northern Europe have become evident, causing changes in the 
epidemiology of tick-transmitted diseases (Beugnet and Marie, 2009; Jongejan and Uilenberg, 2004; 
Leschnik et al., 2002; Medlock and Jameson, 2010). For example, canine babesiosis is a severe and 
often life-threatening disease in dogs, caused by the protozoan Babesia canis which is transmitted by 
Dermacentor reticulatus (Halos et al., 2014). In Switzerland, there is a stable endemic focus in the 
western part of Lake Geneva (Jacquier, 1974; Pfister et al., 1993; Porchet et al., 2007), and four focal 
outbreaks in dogs, without a travel history, have recently been identified in eastern areas of the Swiss 
midplains (Sager et al., 2005; Schaarschmidt et al., 2013, 2006). We have identified a new focus in 
northeastern Switzerland, with 15 confirmed indigenous cases over the last 4 years (unpublished data). 
Therefore we aimed to investigate the occurrence of tick vectors in this region. Data on tick infestations 
of pet animals are rare, and it is presumed that different sampling strategies influence the composition 
of tick samples (Lavender and Oliver, 1996). Most published data on ticks of pet animals were obtained 
with specimens collected in veterinary practices (Claerebout et al., 2013; Földvári and Farkas, 2005; 
Nijhof et al., 2007; Ogden et al., 2000; Papazahariadou et al., 2003; Smith et al., 2011). Alternatively, 
ticks can be collected from the environment, by either experimentally walking dogs in the infested area 
or by flagging (Duscher et al., 2013; Jennett et al., 2013; Leschnik et al., 2012; Schorn et al., 2011). 
Our study describes a systematic and cost-effective, pet owner-based sampling strategy to investigate 
tick occurrence on dogs and cats following an outbreak of canine babesiosis in a town surrounded by 
recreation areas in northeastern Switzerland. 
 
 
Material & Methods 
Study site 
The study was performed in the municipality of Rapperswil-Jona (population of approx. 26’000 
inhabitants), which is located in the eastern part of Switzerland (47.233° N, 8.823° E) on the shores of 
the lake of Zurich. The altitude ranges between 407 m and 544 m above sea level. The vegetation 
around the town is predominantly characterised by deciduous woodland, bushes, agricultural areas 
and some rough grassland, rivers and marsh. The surrounding areas are popular recreation areas and 
attractive sites for dog walking. 
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Tick sampling strategy and identification 
At the beginning of April 2012 and April 2013, letters were sent to all dog owners of the municipality 
(799 and 783 letters were sent in 2012 and 2013, respectively, to a total of 967 people). Their addresses 
were made available by the municipal administration, since all dogs (but not cats) in Switzerland are 
marked by a microchip and are registered (Swiss Federal Council directive No. 916.401). The dog 
owners were invited to collect ticks from their dogs and cats, store the ticks between adhesive tapes 
or in a suitable tube and send them to our laboratory. Furthermore, they were asked to provide data 
on the animals (dog/cat, age, sex, and breed) and on date and putative geographical site of tick 
exposure. The study lasted for two years and was terminated end of March 2014. Tick species, stage 
and gender were determined using standard keys (Estrada-Peña et al., 2004; Hillyard, 1996; Nosek and 
Sixl, 1972), and the ticks were stored individually in 70% ethanol at -20 °C. 
 
Tracking D. reticulatus in the environment 
To verify the presence of D. reticulatus foci, the owners of dogs infested with this species were 
contacted by telephone and asked where exactly they usually walk their dogs. Questing ticks along the 
common walking paths in the 3 identified distinct areas were collected by flagging the vegetation on 
four occasions (twice each in June and September 2012). The cotton flagging blanket was inspected 
every 20 m for the presence of ticks. 
 
DNA isolations and PCRs 
DNA from individual D. reticulatus ticks was extracted according to Wenk et al. (2012) using a mixer 
mill (Retsch®, MM 300). PCRs were performed using two sets of primers, both amplifying part of the 
Babesia spp. 18S rRNA gene as described (Casati et al., 2006; Hilpertshauser et al., 2006). To check 
whether amplifiable DNA was extracted, a tick-specific PCR targeting the mitochondrial 16S rDNA gene 
(Black and Piesman, 1994) was also performed. The latter PCR, combined with direct sequencing of 
the amplicons (Synergene GmbH, Schlieren, Switzerland) was also used to confirm tick species 
identification (Bown et al., 2006). 
 
Case definition and statistical analysis 
Every sample containing ticks was classified as an infestation, and co-infestations (when different tick 
species in the same sample were observed) were counted as different infestation events for each 
species. Thus, an individual animal could give rise to several infestation events, caused by infestations 
at different dates and/or by several tick species. The Pearson’s 2-test was used to analyse differences 
amongst infestation events in dogs and cats for each tick species, and for the number of ticks 
independent of species. Similarly, differences in life stages of the ticks received from dogs and cats 
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were analysed with respect to the total number of ticks per host animal. A p-value < 0.05 was 
considered as statistically significant. Statistical analysis was performed in R version 2.14.2 (R 
development Core Team, 2012). 
 
Results 
In total 967 dog owners were invited by letter twice (April 2012 and 2013) to send ticks from their dogs 
and cats. Data were collected for 2 years after the initiation of the study. Ticks were received from 
18.6% and 16.5% of the dog owners in Year 1 and Year 2, respectively, and 20.7% and 19.1% of the dog 
population was covered (as an owner can have more than one dog). Ticks were submitted in every 
month of the two year study. A total of 3003 ticks (1719 and 1284 per study year) were submitted from 
249 individual dogs and 117 individual cats. From 102 dogs and 11 cats, ticks were sent for both years 
of the investigation. Thus, samples were submitted from 184 and 167 dogs in Year 1 and Year 2 
respectively, and from 64 cats in each of the two years. Overall, 521 and 360 infestation events for 
dogs and 124 and 86 for cats were recorded in the two years, respectively. 
Data about the ticks from dogs and cats are summarised in table 1. Ixodes ricinus was the most 
abundant species representing 96.8% (n=2124) and 74.3% (n=601) of the ticks submitted from dogs 
and cats (statistically significant difference among the host species). Two other tick species, I. 
hexagonus and D. reticulatus, were recorded in both host species, with abundances below 2%. In cats, 
as many as 24.0% (n=194) of the specimens were identified as a fourth tick species, I. trianguliceps. 
The identity of two specimens of each developmental stages of this species was confirmed by PCR and 
sequencing. Of the ticks received, 93.8% and 93.0% were adult ticks isolated from dogs and cats, 
respectively. In contrast, the percentages of nymphs (total 4.4%; 5.7% in dogs and 1% in cats) and 
larvae (total 2%; 0.5% in dogs and 6.0% in cats) were significantly different between the two host 
species. Co-infestations were recorded on only 8 dogs with both I. ricinus and D. reticulatus. The 
number of ticks per infestation event is shown in Fig. 1. The highest intensity of infestation was 49 I. 
ricinus ticks from an individual dog, but 55.6% of the submissions from dogs contained only a single 
tick, whereas in cats this percentage was significantly lower (24.8%). 
The presence of a local population of D. reticulatus was confirmed, by flagging along a 3 km long 
section, in one of the areas where infested dogs were regularly walked (Joner Allmeind, 47.226° N, 
8.856° E). Thus, 5 female and 3 male D. reticulatus as well as 427 I. ricinus were collected. At least one 
Dermacentor specimen was obtained at any of the four collection dates (two each in June and 
September). All Dermacentor ticks received either from pet owners (n=50) or collected by flagging 
(n=8) were PCR-negative for Babesia spp. 
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Discussion 
Our strategy to collect ticks in a newly identified focus of Babesia transmission consisted of 
systematically requesting residential dog owners to collect and send ticks from their pet dogs and cats. 
Thus, ticks from about 20% of the overall resident dog population were obtained. In the first eight 
months after sending the request letters, ticks were obtained from 20.2 and 18.7% of the dog 
population. In a British study covering the 8 months between March and October, 22.9% (810/3534) 
of individual dogs thoroughly inspected at veterinary practices were infested by ticks (Smith et al., 
2011). Thus, the analogous infestations rates found in this previous study and our study confirm that 
our approach is suitable to obtain reasonable estimates of canine tick infestation. The slight decline of 
tick infestations observed in the second year of our study might be caused by the fact that some first 
year participants had improved tick prophylaxis and therefore did not send any ticks in the second 
study year, as they anecdotally reported to us. We are not aware of a report on the extent of tick 
prophylaxis on dogs in Switzerland, but a recent local study involving 29 dogs revealed that around 
55% of the animals had received such treatment (Schaarschmidt et al., 2013). 
Although ticks were submitted in every of the 24 study months, we did not attempt to analyse tick 
seasonality. Numbers of ticks peaked shortly after sending the letters to the animal owners once per 
year and then decreased over the year (data not shown). 
As expected, the vast majority of the submitted ticks (93.5%) were adult stages, consistent with studies 
relying on tick collections by professionals from dogs presented in veterinary practices in Hungary 
(94.8% adult ticks; Földvári and Farkas, 2005) or Belgium (89.2%; Claerebout et al., 2013). Our sampling 
strategy of macroscopic examination by pet owners yielded a comparable number of smaller stages 
nymphs and larvae. In addition, cat owners detected numerous very small I. trianguliceps stages. These 
findings confirm the validity of our approach to collect representative samples of ticks from pets. 
Interestingly, whereas the percentage of developmental stages was comparable in dogs and cats, a 
significantly higher proportion of I. ricinus larvae were sent from cats. This could either be due to the 
fact that cats indeed are more infested by subadult ticks because of behavioural traits or because of a 
more intense interaction of animal owners with their cats (i.e. caressing cat owners detect small ticks 
more effectively).  
In Switzerland, at least 18 different tick species are endemic, and another ten imported species have 
been reported at focal spots from wild and domestic animals (Aeschlimann and Papadopoulos, 1998). 
There is limited information available about the occurrence of these tick species on companion animals 
in Switzerland and neighbouring countries. Only a few of the indigenous tick species have been 
identified on dogs and cats in these countries. These are usually I. ricinus and I. hexagonus. Rarely, D. 
reticulatus, D. marginatus, I. canisuga and Haemaphysalis concinna have been reported, and 
occasionally the imported species Rhipicephalus turanicus and R. sanguineus (Beichel et al., 1996; 
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Capari et al., 2013; Dautel et al., 2006; Duscher et al., 2013; Földvári and Farkas, 2005; Leschnik et al., 
2012; Nijhof et al., 2007; Pfister et al., 1993; Porchet et al., 2007; Sager et al., 2005; Schaarschmidt et 
al., 2013). In our study, 90.7% of the ticks were either I. ricinus or I. hexagonus. D. reticulatus accounted 
for around 1% of the infestations, with comparable rates on dogs and cats. Surprisingly, the second 
most abundant tick species on cats was I. trianguliceps. The nidicolous I. trianguliceps, which is known 
to occur in Switzerland (Aeschlimann and Papadopoulos, 1998), has not, to the best of our knowledge, 
previously been reported on pet animals. It is usually found on rodents (Burri et al., 2011; Jameson and 
Medlock, 2011; Mihalca et al., 2012). Interestingly, I. trianguliceps was found only on cats but not on 
dogs, suggesting an influence of the roaming and rodent-hunting behaviour of cats (but no 
corresponding information was acquired from the cat owners). Again, other studies investigating the 
tick fauna of cats in Europe have never identified I. trianguliceps. The abundant I. ricinus and I. 
hexagonus, have frequently been identified and occasionally I. canisuga and a single I. ventalloi 
(Beichel et al., 1996; Capari et al., 2013; Claerebout et al., 2013; Nijhof et al., 2007; Ogden et al., 2000). 
Ixodes canisuga and I. trianguliceps can clearly be distinguished by morphology (Hillyard, 1996), and 
we have genetically confirmed the identity of eight I. trianguliceps specimens. It remains unclear why 
the cats in this study are the first ever identified population which was frequently infested with I. 
trianguliceps. 
A few ticks of D. reticulatus, the vector species of B. canis, were identified, and this newly identified 
focus of this tick species in eastern Switzerland was subsequently confirmed by collecting questing 
ticks in a marsh-like environment with open meadows, loose trees and intense solar radiation, which 
are tick habitats comparable to those from other reports (Dautel et al., 2006). Dermacentor reticulatus 
could be collected in the field even though the time points of flagging (June and September), chosen 
for organisational reasons, were not during its seasonal peak activity (in March/April and 
October/November). Specimens of this tick species were submitted by animal owners from April to 
June (both years) and in October and November (1st year) and in September (2nd year). 
All Dermacentor ticks collected in this study were tested negative for the presence of Babesia-DNA. 
This is in contrast to 19 of 23 ticks collected from a few square meters in a recreational site in the area 
of another recent canine babesiosis outbreak in the central part of Switzerland (Schaarschmidt et al., 
2013). 
 
Conclusion 
Our study yielded comparable infestation rates and tick species spectra as compared with studies using 
more laborious approaches. In addition, it revealed the presence of an unexpected and probably 
overlooked tick species on cats and allowed to identify environmental habitats of the tick vector of B. 
canis. The sampling strategy which involves animal owners is powerful and cost-effective. 
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Furthermore, improvement might be possible by providing stamped, addressed reply envelopes to 
participating animal owners. 
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Table 
Table 1. Ticks submitted from dogs and cats throughout the two study years. 
 Total 
(%ticksb) 
Adults (%ticksa) Nymphs (%ticksa) Larvae (%ticksa) 
  Female Male   
Dog (n=249):      
I. ricinus 2124 
(96.8) 
1671 (87.7) 319 (15.0) 122 (5.7) 12 (0.6) 
I. hexagonus 26 
(1.2) 
19 (73.1) 7 (26.9) 0 0 
D. reticulatus 44 
(2.0) 
36 (81.8) 5 (11.4) 3 (6.8) 0 
Total 2194 1726 (78.7) 331 (15.1) 125 (5.7) 12 (0.5) 
Cat (n=117):      
I. ricinus 601 
(74.3) 
478 (79.5) 84 (14.0) 6 (1.0) 33 (5.5) 
I. hexagonus 8 
(1.0) 
8 (100) 0 0 0 
I. trianguliceps 194 
(24.0) 
153 (78.9) 23 (11.9) 2 (1.0) 16 (8.2) 
D. reticulatus 6 
(0.7) 
6 (100) 0 0 0 
Total 809 645 (79.7) 107 (13.2) 8 (1.0) 49 (6.1) 
      
Totalc: 3003 2371 (79.0) 438 (14.6) 133 (4.4) 61 (2.0) 
apercentage of ticks (per species) 
bpercentage of all ticks (per host) 
call species 
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Figure 
Figure 1. Number of ticks per infestation event in dogs (a) and cats (b). 
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PART IV DISCUSSION & PERSPECTIVES 
 Discussion 
1.1. General 
Babesia in dogs has been recently characterized as a global emerging disease.1 Although the 
epidemiology and pathophysiology of canine babesiosis has been studied extensively, many questions 
remain unanswered, and the underlying dynamics and molecular mechanisms are still poorly 
characterized. The present thesis addressed different aspects of this important canine disease 
contributing towards an enhanced understanding in pathological and molecular mechanisms of B. 
canis babesiosis, and provides data which can be translated for innovative intervention approaches. 
In particular, I studied the occurrence of the vector-tick Dermacentor reticulatus in an emerging 
epidemiological focus for canine babesiosis (see Part III, Chapter 2.3.). Changes in the endemic foci of 
tick populations and invasion of tick species to new areas have become evident in Europe, leading to 
changes in the epidemiology of tick-transmitted diseases.2-5 Investigations on tick species parasitizing 
companion animals demonstrated that pet owners can contribute to a cost-effective tick surveillance 
leading to the identification of a new tick focus of D. reticulatus in the eastern part of Switzerland. 
Besides, for the first time the presence of the “vole tick” Ixodes trianguliceps was reported exclusively 
on cats, explainable by the free-roaming and rodent hunting behavior of many cats. 
Clinical cases of B. canis infections demonstrate a diversity of disease manifestations, depending 
on a variety of factors, including immune-response and age of the host, as well as the involved parasite 
strain.6,7 By examination and evaluation of the outcome of clinical cases, a better understanding of the 
disease process and pathophysiological mechanisms are provided, resulting in the identification of 
novel routine clinical parameters and thus, to a better prognosis in severe acute infections (see Part 
III, Chapter 2.2.). 
Recent work highlights the central role of parasite-specific exported proteins as potential 
virulence factors with a proposed role as pathogenicity determinants in acute B. canis infections (see 
Part III, Chapter 2.1.). As a prerequisite for transcriptomic- and proteomic analyzes, the whole genome 
of a virulent B. canis isolate from Hungary (BcH-CHIPZ) was assembled and gene models were predicted 
and annotated. Global exportome analysis linked to shot-gun proteomics revealed secreted soluble 
and host membrane-bound proteins involved in the parasite-host interplay. 
All these data and tools provide a basis for the design and evaluation of new intervention 
strategies (diagnosis, vaccination and treatment) and will contribute to an advanced understanding of 
basic concepts in infection biology. 
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1.2. Establishment of indigenous foci of canine babesiosis is dependent on the vector 
distribution 
The incidence of canine babesiosis may vary considerably from one country to another and 
within different regions in a country, depending on the prevalent parasite and their specific vector. 
Hence, even though the climate in most European countries enables the propagation of D. reticulatus, 
the major vector tick for Babesia canis, the distribution of this species is highly focal.4,8 
In Switzerland, there is a stable endemic focus of B. canis in the western part of the Lake Geneva 
with an expansion along the Jura mountains,9-11 and four recent autochthonous outbreaks in the Swiss 
midplains have been published.12-14 Additionally, some other indigenous cases in Switzerland have 
been reported (unpublished data). We have identified a new focus in northeastern Switzerland, with 
15 confirmed cases reported from 2011 to 2014 (see figure IV-1). The presence of the vector tick could 
be demonstrated by the identification of a few D. reticulatus collected over two consecutive years. 
Different factors could be responsible for the establishment of a local transmission cycle, including the 
unusually warm and dry conditions during the recent outbreaks.15 These outbreaks show that the 
resident canine population is immunological naïve resulting in acute and severe disease progressions 
and fatal cases.7 
In the subsequent years, only few new infections have been observed in these dog populations 
(personal communication with local veterinarians). This reduced incidence rate can be attributed to 
the vector-biology, as the distribution of the vector tick D. reticulatus is highly focal.8 For example, in 
one of the recent outbreaks in the Bernese ‘Three Lakes region’ (3 fatal cases from 9 infected dogs) 
infected ticks could be detected by flagging within a few 
square meters.14 Accordingly, I identified one single spot 
with D. reticulatus ticks by flagging. An increased disease 
awareness led to improved diagnostic efforts and to a 
better tick control by highly effective spot-on applications 
and mechanical tick removal.16 Similar dynamics of highly 
focal disease outbreaks in an apparent non-endemic 
region was described in the Netherlands with sporadic B. 
canis infections attributed to focal D. reticulatus foci and 
a subsequent decline of the incidence.17 
In conclusion, monitoring vector and infection 
dynamics could be assisted by pet-owners resulting in a 
cost-effective tick surveillance. Furthermore, vector 
control is an important pillar in an integrated intervention 
approach.18 
Figure IV-1. Geographical distribution of reported 
indigenous cases of B. canis in Switzerland until 2015. 
Reported year(s), in which infection(s) occurred and 
number of cases are documented. Fatal cases are 
highlighted (†). 
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1.3. Clinical pathophysiology and prognostic markers: Are clinical signs host- or parasite 
induced? 
Clinical B. canis babesiosis can manifest itself as mild self-limiting febrile illness or severe forms 
with high mortality.1,19 The clinical outcome of B. canis infections are influenced by many factors and 
the primary pathophysiological mechanisms of canine babesiosis remain unclear.20,21 Accordingly, 
prognosis is not correlated to clinical signs and the level of parasitemia, and a poor response of infusion 
therapy to the protozoal infection and shock is observed.22-24 Measuring host factors as a response to 
the infection can assist in improving the understanding of pathophysiological mechanisms involved in 
host-parasitic interactions. 
The general opinion underlying pathophysiological mechanisms for B. canis babesiosis are the 
uniform involvement of host inflammatory response to the parasite (SIRS and MODS, see Part II), 
rather than direct actions by the parasite itself.21,25,26 Much of the observed clinical data can be 
attributed to an excessive immune-response (including also data from our studies, see Part III, Chapter 
2.2.). Nevertheless, the pathogenesis of several significant factors present in dogs which died from 
acute babesiosis is not well established. This includes exceptional parameters such as the severe 
hyperlactatemia (hypoxic state), severe thrombocytopenia without apparent bleeding, diathesis and 
hemorrhage, and a potential immune-suppressed state by a lasting non-regenerative leukopenia, 
which could not be explained by a single host-response, although these clinical signs can correlate to 
SIRS. Hence, symptoms in complicated babesiosis are often referred as protozoal sepsis, as a 
consequence of dysregulation of the pro-inflammatory and anti-inflammatory mechanism during the 
acute phase of the disease including hypotension and end-organ failure.24,27 It’s likely that the 
multifactorial pathogenesis is triggered by the involvement of parasite-specific factors contributing to 
a severe host response, a mechanism well-described in bacterial sepsis by a range of virulence factors 
and toxins that interact with host cells dysregulating the host immune respons.28 
Sequencing of the B. canis genome (designated as “BcH-CHIPZ”) and bioinformatic approaches 
revealed that the parasite encodes many proteins predicted to be exported and presented to the host, 
therefore potentially involved in pathogenesis. The main exported protein families were the variant 
erythrocyte surface antigens (VESAs), DnaJ- (Hsp40) protein chaperones, the uncharacterized 
‘secreted antigen’ family and members of the previously described Bc28-multigene family.29,30 So far, 
the lack of efficient and effective culture techniques (and reverse genetics) for B. canis hampered the 
screening for virulence-factors. Therefore, we experimentally inoculated dogs aiming in characterizing 
parasite-specific proteins during acute disease. Our proteomic approach revealed 23 highly abundant 
proteins potentially involved in the parasite-host interplay (Part III, Chapter 2.1). Interestingly, proteins 
from different predicted gene families were present during the acute stage of the disease. This includes 
VESA, and Bc28 membrane proteins, and proteins from the ‘secreted antigen’ family. Despite the 
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presence of these potential virulence-factors, their role in pathogenicity has to be elucidated. An 
appropriate approach to address this question is missing, as direct in vivo injection of these proteins 
into dogs is difficult due to animal welfare considerations by the severe outcome of B. canis infections. 
 
1.4. Models for alternative secretory pathways in Babesia canis 
Most secreted proteins in eukaryotic organisms contain an internal signal peptide that direct 
their sorting to the endoplasmic reticulum (ER) and enable proteins to be exported to the extracellular 
space through the ER-Golgi secretory pathway. On the other hand, some cytoplasmic proteins that lack 
an ER-signal peptide have been shown to exit cells through ER-/Golgi independent pathways.31 Many 
macromolecules with unconventional export pathways have been described to be of biomedical 
importance as crucial regulators of the immune response (including inflammatory cytokines in humans 
and animals), cell growth, differentiation and angiogenesis.31 
By mining the B. canis exportome, a significant number of proteins in the predicted exportome 
(210 of 509 proteins) did not show a canonical hydrophobic N-terminal signal peptide for ER targeting. 
This finding is even more prominent by analyzing the B. canis protein families with apicomplexan 
homologues (see Figure 3 in Part III, Chapter 2.1). Although different models for unconventional 
protein secretion have been described,31,32 the presence of these mechanisms in B. canis has yet to be 
shown, whereas initially potential miss-annotation of genes has to be excluded. Nevertheless, non-
mutually exclusive scenarios for potentially unconventional protein secretion are described below in 
brief and schematically illustrated in figure IV-2, for some of which more evidence from the literature 
can be provided and are likely to be present in B. canis. 
Model 1 (pathway 2 in figure IV-2). ER-independent vesicular export of soluble cytosolic proteins 
by direct protein import to a secretory compartment. The Babesia micronemes or spherical bodies 
could represent possible secretory organelles for an alternative vesicular protein export. 
Model 2 (pathway 3 in figure IV-2). Small vesicle and/or exosome-based secretion system 
characterized by protein internalization into micro-vesicle and shedding from cell surface or by direct 
membrane-blebbing. Exosome-like particles have been observed in P. falciparum involved in host 
immune-modulation and inter-parasitic cellular communication 33,34 and could be also an important 
mechanism in non-classical protein export, as it has also been proposed for the protozoan parasite 
Leishmania donovani,35 Trypanosoma cruzi,36 and Trichomonas vaginalis.37 Strikingly, the B. canis BcH-
CHIPZ genome holds homologues of structural and functional proteins found in exosomes, including 
heat shock proteins (e.g. HSP70 and 90), tetraspanins and ALIX protein, TSG101/ESCRT protein, 14-3-
3 protein, thioredoxine peroxidase, histones, and the RAB5, 7, 11, and RABGDI.38-40 
Model 3 (pathway 4 in figure IV-2). Protein export by translocation through membranes 
(parasite and RBC membrane). Non-vesicular export of proteins through different specific parasite-
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induced translocons have been shown for P. falciparum.41 Although export via multiple translocation 
steps may seem at first glance complex and energy-consuming, such a system could be more efficient 
than the establishment of a vesicular trafficking system through different membranes in a host cell 
(RBC) that is highly differentiated and has lost any trafficking mechanisms. The presence of a number 
of apicomplexan chaperones found in the host cell (including DnaJ/HSP40 chaperones in the B. canis 
exportome) might contribute to retain the secreted proteins in a translocation-competent form and 
could assist in the recruitment and translocation of specific proteins.42,43 
Model 4 (pathway 5 in figure IV-2). Protein export by membrane interaction of transmembrane 
domain-containing proteins. A potential mechanism is described for the Leishmania HASPB 
(hydrophilic acylated surface protein B) which is found associated with the outer leaflet of the plasma 
membrane only in the infectious stages of the parasite’s lifecycle.44,45 The protein is synthesized on 
free ribosomes in the cytoplasm and becomes both myristoylated and palmitoylated at its N-terminus 
(co- and posttranslational modification with saturated fatty acids chains), which is the molecular basis 
of how HASPB is anchored to the membrane.46 Cytoplasmic HASPB is transferred to the outer leaflet 
of the Golgi membrane, from where it is transported to the plasma membrane via conventional 
vesicular transport. This process would insert HASPB into the inner leaflet of the plasma membrane. 
Presently, this model could not explain how a protein is then translocated across the membrane. A 
potential membrane-flipping step has to be involved.32 Recently, alternative secretion in P. falciparum 
by posttranslational myristoylation and palmitoylation of proteins lacking an ER-signal peptide was 
demonstrated.47 Furthermore, in other apicomplexans such as T. gondii, palmitoylation is highly 
prevalent.48 
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Figure IV-2. Potential export routes of unconventional protein secretion in Babesia canis. Classical protein export 
pathways starting from translation at the rough endoplasmic reticulum followed by vesicular export including the Golgi 
network and secretory organelles (SB, MIC, RH) shown in the first pathway (1. Alternatively, unconventional export includes 
vesicular export by by-passing the ER to the parasite surface or the secretory organelles (2), by membrane-budding of 
microvesicles enclosing cytosolic proteins derived from free ribosomes (RIB) or by the export of exosome-like vesicles 
derived from early endosomes (END) and the fusion of multi-vesicular bodies (MVB) with the parasite plasma membrane 
(3). Further protein export includes the translocation of proteins through the plasma membrane (parasite and RBC) by 
parasite specific translocons (4). Membrane interaction/integration and export of co- and posttranslationally (e.g. 
palmitoylation and myristoylation) modified proteins include a so far undiscovered membrane flipping mechanism (5). END: 
early endosome; ER: endoplasmic reticulum: G: Golgi; MIC: micronemes; MVB: multi-vesicular body; N: nucleus; RBC: red 
blood cell; RH: rhoptry; RIB: free ribosomes; SB: spherical body; T: translocon.  
 Perspectives 
Providing the whole genome of a virulent B. canis strain generated a powerful toolbox for 
further comparative studies and applications. Although robust in vitro culture techniques and reverse 
genetic approaches are not available to date, the here generated transcriptomic and proteomic data 
of blood-stage parasites give important clues about the pathophysiology of apicomplexan blood 
parasites. Therefore, the data could be translated to innovative intervention approaches, most needed 
novel diagnostic tools and effective vaccines. 
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2.1. Screening for diagnostic and vaccine candidates 
Acute canine babesiosis represents an emergency situation and requires an early and accurate 
diagnosis for the immediate chemotherapy to increase the chance for survival.7 In acute infections, 
diagnosis is routinely based on the direct demonstration of parasites in Giemsa-stained blood smears 
allowing a prompt diagnosis by experienced investigators. However, comparable to our studies, in 
subclinical-, latent-, but also in acute infections in animals with severe clinical symptoms, 
morphological diagnosis is aggravated by low parasitemia and a frequent absence of detectable 
parasites.22,49,50 Therefore, innovative diagnostics are needed, for example as a rapid 
immunochromatographic test assay like it is applied for human malaria.51,52 The gene models identified 
in this study and our in silico analyses provide many possible targets for further investigations. A 
potential list of proteins includes merozoite- and iRBC membrane antigens like proteins from the Bc28 
multigene family,30 apicomplexan conserved proteins with supposed species specificity like 
thrombospondin-related adhesive proteins,53 and rhoptry-associated proteins,54 as well as parasite 
aldolase, lactate dehydrogenase, and histidine rich proteins, known targets in rapid diagnostic tests 
for the diagnosis of malaria.55 Hence, our studies may lead to the development of novel diagnostic 
tools. 
Vaccines would be an ideal protective prevention method. However, the development of 
effective vaccines is hampered by the complexity and invasive biology of apicomplexan parasites which 
pass through multiple developmental stages, each stage expressing hundreds of unique antigens 
including further clonal variations. In fact, vaccine candidates against any apicomplexan parasite with 
this breadth of targets show limited vaccine’s efficacy. Accordingly, the most prominent example is the 
commercialized human malaria vaccine ‘RTS,S’ (Mosquirix®, GlaxoSmithKline, UK) with 26% and 36% 
efficacy in infants and children, respectively.56 Furthermore, for B. canis a vaccine formulation is on the 
market (Pirodog®, Merial, France). This crude formulation based on soluble parasite antigens (SPA) 
from infected blood culture only protects against severe clinical manifestations in some B. canis 
strains.57 Adversely, uncharacterized crude protein fractions could include potential immune-
modulatory proteins which minimize immune-stimulation and vaccine efficacy.58 Parasite proteins 
displayed during the parasitic cycle (mainly extracellular phase and cell invasion) are promising vaccine 
candidates.59 The annotation of the Hungarian B. canis CHIPZ genome and subsequent prediction of 
the B. canis exportome provides a framework for potential vaccine target candidates. This includes 
proteins from the Bc28 protein family, which are highly expressed at the merozoite surface30 and are 
also present during virulent infection. Naturally acquired antibody response targeting particularly the 
merozoite surface has a protective effect in human malaria suggesting that the recombinant proteins 
may be efficient vaccine candidates.60 
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In the absence of stable in vitro culturing systems for B. canis, in silico prediction of the parasite-
host interactome could further assist in the screening for protein candidates. Mainly two different 
computational approaches have been described: i) Homology and structure based approaches and ii) 
domain and motif interaction based approaches, which both include in silico machine training/learning 
and data mining.61 Nevertheless, all current prediction approaches lack biological evidence and result 
in high false positive rates and are not reliable to replace biophysical approaches and animal 
experiments.62 A further approach for high throughput immunological screening of protein candidates 
are cell-free expression systems, which represent simple and efficient protein production platforms.63-
65 They are based on linear or plasmid based DNA-templates applicable in multi-well format allowing 
to by-pass multiple steps, which are typically required using conventional in vivo protein expression 
systems. In summary, the herein provided data forms the backbone for future improvements in 
fighting B. canis including parasites own proteomic targets. 
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